[
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55021673
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0003124"
      ],
      "reported_trait_name": "High cholesterol | non-cancer illness code, self-reported",
      "standard_trait_name": "Hypercholesterolemia"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1473",
      "neg_log_pval": 28.214189147749966,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55023869
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0003124"
      ],
      "reported_trait_name": "Hypercholesterolemia",
      "standard_trait_name": "Hypercholesterolemia"
    },
    "association_info": {
      "ancestry": [
        "European=406276"
      ],
      "otg_id": "SAIGE_272_11",
      "neg_log_pval": 11.88941028970075,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55023869
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "Orphanet_309005"
      ],
      "reported_trait_name": "Disorders of lipoid metabolism",
      "standard_trait_name": "Disorder of lipid metabolism"
    },
    "association_info": {
      "ancestry": [
        "European=408961"
      ],
      "otg_id": "SAIGE_272",
      "neg_log_pval": 12.71669877129645,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication Disorder of lipid metabolism (Orphanet_309005) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55030366
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "European=141217",
        "African American or Afro-Caribbean=3139",
        "Hispanic or Latin American=4095",
        "South Asian=25557",
        "Greater Middle Eastern (Middle Eastern / North African / Persian)=2268",
        "East Asian=11323"
      ],
      "otg_id": "GCST003116",
      "neg_log_pval": 7.698970004336019,
      "gwas_catalog_id": "GCST003116",
      "pubmed_id": "26343387"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EVOLOCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55030366
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Myocardial infarction (early onset)",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "European=6042"
      ],
      "otg_id": "GCST000340",
      "neg_log_pval": 8.0,
      "gwas_catalog_id": "GCST000340",
      "pubmed_id": "19198609"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EVOLOCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55039974
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0003124"
      ],
      "reported_trait_name": "Hypercholesterolemia",
      "standard_trait_name": "Hypercholesterolemia"
    },
    "association_info": {
      "ancestry": [
        "European=406276"
      ],
      "otg_id": "SAIGE_272_11",
      "neg_log_pval": 20.25103713874384,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55039974
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0003124"
      ],
      "reported_trait_name": "High cholesterol | non-cancer illness code, self-reported",
      "standard_trait_name": "Hypercholesterolemia"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1473",
      "neg_log_pval": 64.89219328560758,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55039974
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "European, NR=63731"
      ],
      "otg_id": "GCST004787",
      "neg_log_pval": 9.522878745280337,
      "gwas_catalog_id": "GCST004787",
      "pubmed_id": "28714975"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EVOLOCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55039974
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=547261"
      ],
      "otg_id": "GCST005195",
      "neg_log_pval": 17.82390874094432,
      "gwas_catalog_id": "GCST005195",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EVOLOCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55039974
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Ischemic heart disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "European=408458"
      ],
      "otg_id": "SAIGE_411",
      "neg_log_pval": 11.844663962534938,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EVOLOCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55039974
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "MONDO_0021661"
      ],
      "reported_trait_name": "Coronary atherosclerosis",
      "standard_trait_name": "coronary atherosclerosis"
    },
    "association_info": {
      "ancestry": [
        "European=397126"
      ],
      "otg_id": "SAIGE_411_4",
      "neg_log_pval": 11.230622673923861,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication atherosclerosis (EFO_0003914) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55039974
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=250736"
      ],
      "otg_id": "GCST005196",
      "neg_log_pval": 24.69897000433602,
      "gwas_catalog_id": "GCST005196",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EVOLOCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55039974
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=296525"
      ],
      "otg_id": "GCST005194",
      "neg_log_pval": 21.731656086048936,
      "gwas_catalog_id": "GCST005194",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EVOLOCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55039974
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "Orphanet_309005"
      ],
      "reported_trait_name": "Disorders of lipoid metabolism",
      "standard_trait_name": "Disorder of lipid metabolism"
    },
    "association_info": {
      "ancestry": [
        "European=408961"
      ],
      "otg_id": "SAIGE_272",
      "neg_log_pval": 23.614393726401687,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication Disorder of lipid metabolism (Orphanet_309005) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 55055640
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0003124"
      ],
      "reported_trait_name": "High cholesterol | non-cancer illness code, self-reported",
      "standard_trait_name": "Hypercholesterolemia"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1473",
      "neg_log_pval": 14.0,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169174",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALIROCUMAB is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000169174 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 153689947
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension | non-cancer illness code, self-reported",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1065",
      "neg_log_pval": 10.209025579976215,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169418",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NESIRITIDE is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000169418 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 155157915
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003898"
      ],
      "reported_trait_name": "Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",
      "standard_trait_name": "ankylosing spondylitis"
    },
    "association_info": {
      "ancestry": [
        "European=86475"
      ],
      "otg_id": "GCST005537",
      "neg_log_pval": 9.522878745280337,
      "gwas_catalog_id": "GCST005537",
      "pubmed_id": "26974007"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000160752",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PAMIDRONIC ACID is approved for the indication ankylosing spondylitis (EFO_0003898) and targets the gene ENSG00000160752 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 155176305
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=139274"
      ],
      "otg_id": "GCST004988",
      "neg_log_pval": 10.316502682320188,
      "gwas_catalog_id": "GCST004988",
      "pubmed_id": "29059683"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000160752",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PAMIDRONIC ACID is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000160752 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ZOLEDRONIC ACID is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000160752 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug RISEDRONIC ACID is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000160752 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 169542317
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0004418"
      ],
      "reported_trait_name": "Phlebitis and thrombophlebitis of lower extremities",
      "standard_trait_name": "Thrombophlebitis"
    },
    "association_info": {
      "ancestry": [
        "European=373179"
      ],
      "otg_id": "SAIGE_451_2",
      "neg_log_pval": 12.838631997765026,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000198734",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DROTRECOGIN ALFA (ACTIVATED) is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000198734 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 169542317
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0004418"
      ],
      "reported_trait_name": "Phlebitis and thrombophlebitis",
      "standard_trait_name": "Thrombophlebitis"
    },
    "association_info": {
      "ancestry": [
        "European=373492"
      ],
      "otg_id": "SAIGE_451",
      "neg_log_pval": 13.468521082957745,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000198734",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DROTRECOGIN ALFA (ACTIVATED) is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000198734 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 169549811
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0004418"
      ],
      "reported_trait_name": "Phlebitis and thrombophlebitis",
      "standard_trait_name": "Thrombophlebitis"
    },
    "association_info": {
      "ancestry": [
        "European=373492"
      ],
      "otg_id": "SAIGE_451",
      "neg_log_pval": 107.58838029403677,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000198734",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DROTRECOGIN ALFA (ACTIVATED) is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000198734 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 169549811
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0004418"
      ],
      "reported_trait_name": "Phlebitis and thrombophlebitis of lower extremities",
      "standard_trait_name": "Thrombophlebitis"
    },
    "association_info": {
      "ancestry": [
        "European=373179"
      ],
      "otg_id": "SAIGE_451_2",
      "neg_log_pval": 109.5702477199976,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000198734",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DROTRECOGIN ALFA (ACTIVATED) is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000198734 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 169549811
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003907"
      ],
      "reported_trait_name": "Deep venous thrombosis (dvt) | non-cancer illness code, self-reported",
      "standard_trait_name": "deep vein thrombosis"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1094",
      "neg_log_pval": 174.4767661470527,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000198734",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DROTRECOGIN ALFA (ACTIVATED) is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000198734 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 169549811
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003907"
      ],
      "reported_trait_name": "Thrombosis",
      "standard_trait_name": "deep vein thrombosis"
    },
    "association_info": {
      "ancestry": [
        "European=258962"
      ],
      "otg_id": "GCST003390",
      "neg_log_pval": 136.39794000867204,
      "gwas_catalog_id": "GCST003390",
      "pubmed_id": "26908601"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000198734",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DROTRECOGIN ALFA (ACTIVATED) is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000198734 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 169549811
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003907"
      ],
      "reported_trait_name": "Blood clot in the leg (dvt) | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",
      "standard_trait_name": "deep vein thrombosis"
    },
    "association_info": {
      "ancestry": [
        "European=360527"
      ],
      "otg_id": "NEALE2_6152_5",
      "neg_log_pval": 182.1308557348547,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000198734",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DROTRECOGIN ALFA (ACTIVATED) is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000198734 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 215131342
      },
      "alleles": {
        "reference": "TATA",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension | non-cancer illness code, self-reported",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1065",
      "neg_log_pval": 8.172660456455034,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000082482",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SEVOFLURANE is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000082482 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "1",
        "position": 239737706
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000341"
      ],
      "reported_trait_name": "Chronic obstructive pulmonary disease",
      "standard_trait_name": "chronic obstructive pulmonary disease"
    },
    "association_info": {
      "ancestry": [
        "European, East Asian, African American or Afro-Caribbean, Hispanic or Latin American, NR=257811"
      ],
      "otg_id": "GCST007692",
      "neg_log_pval": 8.154901959985743,
      "gwas_catalog_id": "GCST007692",
      "pubmed_id": "30804561"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000133019",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TIOTROPIUM is approved for the indication chronic obstructive pulmonary disease (EFO_0000341) and targets the gene ENSG00000133019 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ACLIDINIUM is approved for the indication chronic obstructive pulmonary disease (EFO_0000341) and targets the gene ENSG00000133019 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UMECLIDINIUM is approved for the indication chronic obstructive pulmonary disease (EFO_0000341) and targets the gene ENSG00000133019 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug IPRATROPIUM is approved for the indication chronic obstructive pulmonary disease (EFO_0000341) and targets the gene ENSG00000133019 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug GLYCOPYRRONIUM is approved for the indication chronic obstructive pulmonary disease (EFO_0000341) and targets the gene ENSG00000133019 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "10",
        "position": 6056986
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0005140"
      ],
      "reported_trait_name": "Autoimmune traits",
      "standard_trait_name": "autoimmune disease"
    },
    "association_info": {
      "ancestry": [
        "European=459000"
      ],
      "otg_id": "GCST007071",
      "neg_log_pval": 17.397940008672037,
      "gwas_catalog_id": "GCST007071",
      "pubmed_id": "30595370"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000134460",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BASILIXIMAB is approved for the indication immune system disease (EFO_0000540) and targets the gene ENSG00000134460 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DACLIZUMAB is approved for the indication immune system disease (EFO_0000540) and targets the gene ENSG00000134460 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "10",
        "position": 6060049
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003885"
      ],
      "reported_trait_name": "Multiple sclerosis",
      "standard_trait_name": "multiple sclerosis"
    },
    "association_info": {
      "ancestry": [
        "European=5224"
      ],
      "otg_id": "GCST000062",
      "neg_log_pval": 7.522878745280337,
      "gwas_catalog_id": "GCST000062",
      "pubmed_id": "17660530"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000134460",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DACLIZUMAB is approved for the indication relapsing-remitting multiple sclerosis (EFO_0003929) and targets the gene ENSG00000134460 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "10",
        "position": 6081532
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001359"
      ],
      "reported_trait_name": "Type 1 diabetes",
      "standard_trait_name": "insulin-dependent diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=16559"
      ],
      "otg_id": "GCST000392",
      "neg_log_pval": 13.0,
      "gwas_catalog_id": "GCST000392",
      "pubmed_id": "19430480"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000134460",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BASILIXIMAB is approved for the indication diabetes mellitus (EFO_0000400) and targets the gene ENSG00000134460 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "10",
        "position": 102654464
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001663"
      ],
      "reported_trait_name": "Prostate cancer",
      "standard_trait_name": "prostate carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=22548"
      ],
      "otg_id": "GCST001942",
      "neg_log_pval": 9.301029995663981,
      "gwas_catalog_id": "GCST001942",
      "pubmed_id": "23535732"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000148795",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABIRATERONE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000148795 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABIRATERONE ACETATE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000148795 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "10",
        "position": 102654464
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001663"
      ],
      "reported_trait_name": "Prostate cancer",
      "standard_trait_name": "prostate carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=140254"
      ],
      "otg_id": "GCST006085",
      "neg_log_pval": 15.221848749616356,
      "gwas_catalog_id": "GCST006085",
      "pubmed_id": "29892016"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000148795",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABIRATERONE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000148795 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABIRATERONE ACETATE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000148795 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "10",
        "position": 113963919
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension | non-cancer illness code, self-reported",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1065",
      "neg_log_pval": 8.399595651036623,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000043591",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NEBIVOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ATENOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ACEBUTOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BISOPROLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PROPRANOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METOPROLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NADOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "10",
        "position": 113982069
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension [East Asian]",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "East Asian=50792"
      ],
      "otg_id": "GCST007707",
      "neg_log_pval": 8.698970004336019,
      "gwas_catalog_id": "GCST007707",
      "pubmed_id": "30487518"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000043591",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NEBIVOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ATENOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ACEBUTOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BISOPROLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PROPRANOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METOPROLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NADOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "10",
        "position": 114033028
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension | non-cancer illness code, self-reported",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1065",
      "neg_log_pval": 21.73008330295326,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000043591",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NEBIVOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ATENOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ACEBUTOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BISOPROLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PROPRANOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METOPROLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NADOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "10",
        "position": 114045297
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Essential hypertension",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=408089"
      ],
      "otg_id": "SAIGE_401_1",
      "neg_log_pval": 14.522878745280337,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000043591",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NEBIVOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ATENOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ACEBUTOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BISOPROLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PROPRANOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METOPROLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NADOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "10",
        "position": 114045297
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=408343"
      ],
      "otg_id": "SAIGE_401",
      "neg_log_pval": 14.397940008672037,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000043591",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NEBIVOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ATENOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ACEBUTOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BISOPROLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PROPRANOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METOPROLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NADOLOL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000043591 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "11",
        "position": 46684189
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003827"
      ],
      "reported_trait_name": "Pulmonary embolism +/- dvt | non-cancer illness code, self-reported",
      "standard_trait_name": "pulmonary embolism"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1093",
      "neg_log_pval": 13.853871964321762,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000180210",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN ETEXILATE is approved for the indication pulmonary embolism (EFO_0003827) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN is approved for the indication pulmonary embolism (EFO_0003827) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "11",
        "position": 46739206
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0004286"
      ],
      "reported_trait_name": "Venous thromboembolism [Conditioned on rs1799963]",
      "standard_trait_name": "venous thromboembolism"
    },
    "association_info": {
      "ancestry": [
        "European=120158"
      ],
      "otg_id": "GCST004256_2",
      "neg_log_pval": 8.096910013008056,
      "gwas_catalog_id": "GCST004256",
      "pubmed_id": "28373160"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000180210",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN is approved for the indication venous thromboembolism (EFO_0004286) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "11",
        "position": 46739505
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0004286"
      ],
      "reported_trait_name": "Venous thromboembolism",
      "standard_trait_name": "venous thromboembolism"
    },
    "association_info": {
      "ancestry": [
        "European=60139"
      ],
      "otg_id": "GCST002808",
      "neg_log_pval": 8.698970004336019,
      "gwas_catalog_id": "GCST002808",
      "pubmed_id": "25772935"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000180210",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN is approved for the indication venous thromboembolism (EFO_0004286) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "11",
        "position": 46739505
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0004286"
      ],
      "reported_trait_name": "Venous thromboembolism",
      "standard_trait_name": "venous thromboembolism"
    },
    "association_info": {
      "ancestry": [
        "European=120158"
      ],
      "otg_id": "GCST004256",
      "neg_log_pval": 12.301029995663981,
      "gwas_catalog_id": "GCST004256",
      "pubmed_id": "28373160"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000180210",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN is approved for the indication venous thromboembolism (EFO_0004286) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "11",
        "position": 46739505
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0004418"
      ],
      "reported_trait_name": "Phlebitis and thrombophlebitis",
      "standard_trait_name": "Thrombophlebitis"
    },
    "association_info": {
      "ancestry": [
        "European=373492"
      ],
      "otg_id": "SAIGE_451",
      "neg_log_pval": 10.41907502432438,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000180210",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BIVALIRUDIN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DESIRUDIN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ARGATROBAN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug XIMELAGATRAN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN ETEXILATE is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug LEPIRUDIN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "11",
        "position": 46739505
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003907"
      ],
      "reported_trait_name": "Blood clot in the leg (dvt) | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",
      "standard_trait_name": "deep vein thrombosis"
    },
    "association_info": {
      "ancestry": [
        "European=360527"
      ],
      "otg_id": "NEALE2_6152_5",
      "neg_log_pval": 19.56919957537582,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000180210",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN ETEXILATE is approved for the indication deep vein thrombosis (EFO_0003907) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DESIRUDIN is approved for the indication deep vein thrombosis (EFO_0003907) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "11",
        "position": 46739505
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003827"
      ],
      "reported_trait_name": "Blood clot in the lung | blood clot, dvt, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor",
      "standard_trait_name": "pulmonary embolism"
    },
    "association_info": {
      "ancestry": [
        "European=360527"
      ],
      "otg_id": "NEALE2_6152_7",
      "neg_log_pval": 12.362510270487489,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000180210",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN ETEXILATE is approved for the indication pulmonary embolism (EFO_0003827) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN is approved for the indication pulmonary embolism (EFO_0003827) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "11",
        "position": 46739505
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003907"
      ],
      "reported_trait_name": "Deep venous thrombosis (dvt) | non-cancer illness code, self-reported",
      "standard_trait_name": "deep vein thrombosis"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1094",
      "neg_log_pval": 20.081541349622885,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000180210",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN ETEXILATE is approved for the indication deep vein thrombosis (EFO_0003907) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DESIRUDIN is approved for the indication deep vein thrombosis (EFO_0003907) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "11",
        "position": 46739505
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0004418"
      ],
      "reported_trait_name": "Phlebitis and thrombophlebitis of lower extremities",
      "standard_trait_name": "Thrombophlebitis"
    },
    "association_info": {
      "ancestry": [
        "European=373179"
      ],
      "otg_id": "SAIGE_451_2",
      "neg_log_pval": 11.153044674980176,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000180210",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BIVALIRUDIN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DESIRUDIN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ARGATROBAN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug XIMELAGATRAN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN ETEXILATE is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug LEPIRUDIN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "11",
        "position": 46739505
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003907"
      ],
      "reported_trait_name": "Thrombosis",
      "standard_trait_name": "deep vein thrombosis"
    },
    "association_info": {
      "ancestry": [
        "European=258962"
      ],
      "otg_id": "GCST003390",
      "neg_log_pval": 24.0,
      "gwas_catalog_id": "GCST003390",
      "pubmed_id": "26908601"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000180210",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BIVALIRUDIN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DESIRUDIN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ARGATROBAN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug XIMELAGATRAN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DABIGATRAN ETEXILATE is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug LEPIRUDIN is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000180210 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 6330843
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0004267"
      ],
      "reported_trait_name": "Primary biliary cholangitis",
      "standard_trait_name": "biliary liver cirrhosis"
    },
    "association_info": {
      "ancestry": [
        "European=7003"
      ],
      "otg_id": "GCST001010",
      "neg_log_pval": 8.698970004336019,
      "gwas_catalog_id": "GCST001010",
      "pubmed_id": "21399635"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000111319",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRIAMTERENE is approved for the indication cirrhosis of liver (EFO_0001422) and targets the gene ENSG00000111319 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 20424659
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0002140"
      ],
      "reported_trait_name": "Ischemic stroke",
      "standard_trait_name": "Ischemic stroke"
    },
    "association_info": {
      "ancestry": [
        "European=440328",
        "East Asian=45564",
        "South Asian=9144",
        "African American or Afro-Caribbean=20687",
        "Asian unspecified=555",
        "Hispanic or Latin American=1247"
      ],
      "otg_id": "GCST005843",
      "neg_log_pval": 7.301029995663981,
      "gwas_catalog_id": "GCST005843",
      "pubmed_id": "29531354"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000172572",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CILOSTAZOL is approved for the indication Ischemic stroke (HP_0002140) and targets the gene ENSG00000172572 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 20424659
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0002140"
      ],
      "reported_trait_name": "Ischemic stroke",
      "standard_trait_name": "Ischemic stroke"
    },
    "association_info": {
      "ancestry": [
        "European=440328",
        "East Asian=45564",
        "South Asian=9144",
        "African American or Afro-Caribbean=20687",
        "Asian unspecified=555",
        "Hispanic or Latin American=1247"
      ],
      "otg_id": "GCST005843",
      "neg_log_pval": 7.301029995663981,
      "gwas_catalog_id": "GCST005843",
      "pubmed_id": "29531354"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000172572",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CILOSTAZOL is approved for the indication Ischemic stroke (HP_0002140) and targets the gene ENSG00000172572 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 47792780
      },
      "alleles": {
        "reference": "T",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension | non-cancer illness code, self-reported",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1065",
      "neg_log_pval": 8.267891037697892,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000111424",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CHOLECALCIFEROL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 47792780
      },
      "alleles": {
        "reference": "T",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1002011"
      ],
      "reported_trait_name": "Asthma (adult onset)",
      "standard_trait_name": "adult onset asthma"
    },
    "association_info": {
      "ancestry": [
        "European=327253"
      ],
      "otg_id": "GCST007799",
      "neg_log_pval": 12.698970004336019,
      "gwas_catalog_id": "GCST007799",
      "pubmed_id": "30929738"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000111424",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CALCIFEDIOL is approved for the indication asthma (EFO_0000270) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALFACALCIDOL is approved for the indication asthma (EFO_0000270) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CHOLECALCIFEROL is approved for the indication asthma (EFO_0000270) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ERGOCALCIFEROL is approved for the indication asthma (EFO_0000270) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CALCITRIOL is approved for the indication asthma (EFO_0000270) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 47802090
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003785"
      ],
      "reported_trait_name": "Allergic disease (asthma, hay fever or eczema)",
      "standard_trait_name": "allergy"
    },
    "association_info": {
      "ancestry": [
        "European=360838"
      ],
      "otg_id": "GCST005038",
      "neg_log_pval": 10.941953769604718,
      "gwas_catalog_id": "GCST005038",
      "pubmed_id": "29083406"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000111424",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CHOLECALCIFEROL is approved for the indication seasonal allergic rhinitis (EFO_0003956) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 47810716
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000341"
      ],
      "reported_trait_name": "Chronic obstructive pulmonary disease or high blood pressure (pleiotropy)",
      "standard_trait_name": "chronic obstructive pulmonary disease"
    },
    "association_info": {
      "ancestry": [
        "European, NR=58918",
        "European=458554"
      ],
      "otg_id": "GCST007611",
      "neg_log_pval": 10.154901959985743,
      "gwas_catalog_id": "GCST007611",
      "pubmed_id": "30940143"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000111424",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CHOLECALCIFEROL is approved for the indication chronic obstructive pulmonary disease (EFO_0000341) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 47814585
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003767"
      ],
      "reported_trait_name": "Inflammatory bowel disease",
      "standard_trait_name": "inflammatory bowel disease"
    },
    "association_info": {
      "ancestry": [
        "European=34366"
      ],
      "otg_id": "GCST001725",
      "neg_log_pval": 7.338187314462739,
      "gwas_catalog_id": "GCST001725",
      "pubmed_id": "23128233"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000111424",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CHOLECALCIFEROL is approved for the indication Crohn's disease (EFO_0000384) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ERGOCALCIFEROL is approved for the indication Crohn's disease (EFO_0000384) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 47860570
      },
      "alleles": {
        "reference": "T",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension | non-cancer illness code, self-reported",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1065",
      "neg_log_pval": 12.517126416391246,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000111424",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CHOLECALCIFEROL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 48021974
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000685"
      ],
      "reported_trait_name": "Rheumatoid arthritis",
      "standard_trait_name": "rheumatoid arthritis"
    },
    "association_info": {
      "ancestry": [
        "European=2062"
      ],
      "otg_id": "GCST007843",
      "neg_log_pval": 11.522878745280337,
      "gwas_catalog_id": "GCST007843",
      "pubmed_id": "30891314"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000111424",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ERGOCALCIFEROL is approved for the indication rheumatoid arthritis (EFO_0000685) and targets the gene ENSG00000111424 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 56344189
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=12244"
      ],
      "otg_id": "GCST002738",
      "neg_log_pval": 9.221848749616356,
      "gwas_catalog_id": "GCST002738",
      "pubmed_id": "25574825"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000110944",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug GUSELKUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000110944 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 56344189
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=2759"
      ],
      "otg_id": "GCST000322",
      "neg_log_pval": 9.0,
      "gwas_catalog_id": "GCST000322",
      "pubmed_id": "19169254"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000110944",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug GUSELKUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000110944 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 56346898
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis [EA]",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5134",
        "European=8682"
      ],
      "otg_id": "GCST002874_8",
      "neg_log_pval": 10.0,
      "gwas_catalog_id": "GCST002874",
      "pubmed_id": "25903422"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000110944",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug GUSELKUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000110944 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 56346898
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5134",
        "European=8682"
      ],
      "otg_id": "GCST002874",
      "neg_log_pval": 11.301029995663981,
      "gwas_catalog_id": "GCST002874",
      "pubmed_id": "25903422"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000110944",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug GUSELKUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000110944 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 56347444
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=287323"
      ],
      "otg_id": "GCST004346",
      "neg_log_pval": 24.397940008672037,
      "gwas_catalog_id": "GCST004346",
      "pubmed_id": "28537254"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000110944",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug GUSELKUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000110944 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 56350492
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Inflammatory skin disease [Psoriasis]",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=18190"
      ],
      "otg_id": "GCST002740_4",
      "neg_log_pval": 11.698970004336019,
      "gwas_catalog_id": "GCST002740",
      "pubmed_id": "25574825"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000110944",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug GUSELKUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000110944 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 56356420
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1001494"
      ],
      "reported_trait_name": "Psoriasis vulgaris",
      "standard_trait_name": "psoriasis vulgaris"
    },
    "association_info": {
      "ancestry": [
        "European=8941"
      ],
      "otg_id": "GCST003268",
      "neg_log_pval": 14.397940008672037,
      "gwas_catalog_id": "GCST003268",
      "pubmed_id": "26626624"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000110944",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug GUSELKUMAB is approved for the indication psoriasis vulgaris (EFO_1001494) and targets the gene ENSG00000110944 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "12",
        "position": 111803962
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003829"
      ],
      "reported_trait_name": "Alcohol dependence",
      "standard_trait_name": "alcohol dependence"
    },
    "association_info": {
      "ancestry": [
        "East Asian=314"
      ],
      "otg_id": "GCST002293",
      "neg_log_pval": 7.301029995663981,
      "gwas_catalog_id": "GCST002293",
      "pubmed_id": "24277619"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000111275",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DISULFIRAM is approved for the indication alcohol dependence (EFO_0003829) and targets the gene ENSG00000111275 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "13",
        "position": 42378009
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003882"
      ],
      "reported_trait_name": "Osteoporosis | non-cancer illness code, self-reported",
      "standard_trait_name": "osteoporosis"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1309",
      "neg_log_pval": 11.549904924128398,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000120659",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DENOSUMAB is approved for the indication osteoporosis (EFO_0003882) and targets the gene ENSG00000120659 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "14",
        "position": 64219489
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003761"
      ],
      "reported_trait_name": "Depression",
      "standard_trait_name": "unipolar depression"
    },
    "association_info": {
      "ancestry": [
        "European=480359"
      ],
      "otg_id": "GCST005839",
      "neg_log_pval": 9.096910013008056,
      "gwas_catalog_id": "GCST005839",
      "pubmed_id": "29700475"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000140009",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug RALOXIFENE is approved for the indication unipolar depression (EFO_0003761) and targets the gene ENSG00000140009 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "14",
        "position": 64230319
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003761"
      ],
      "reported_trait_name": "Depression",
      "standard_trait_name": "unipolar depression"
    },
    "association_info": {
      "ancestry": [
        "NR=361315",
        "European=446238"
      ],
      "otg_id": "GCST007342",
      "neg_log_pval": 11.397940008672037,
      "gwas_catalog_id": "GCST007342",
      "pubmed_id": "30718901"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000140009",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug RALOXIFENE is approved for the indication unipolar depression (EFO_0003761) and targets the gene ENSG00000140009 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "15",
        "position": 63445726
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003144"
      ],
      "reported_trait_name": "Heart failure [EA]",
      "standard_trait_name": "heart failure"
    },
    "association_info": {
      "ancestry": [
        "European=20926",
        "African American or Afro-Caribbean=2895"
      ],
      "otg_id": "GCST000675_2",
      "neg_log_pval": 8.0,
      "gwas_catalog_id": "GCST000675",
      "pubmed_id": "20445134"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000074410",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ACETAZOLAMIDE is approved for the indication heart failure (EFO_0003144) and targets the gene ENSG00000074410 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "15",
        "position": 73359833
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=59133"
      ],
      "otg_id": "GCST001499",
      "neg_log_pval": 16.522878745280337,
      "gwas_catalog_id": "GCST001499",
      "pubmed_id": "22544366"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000138622",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DRONEDARONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000138622 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "15",
        "position": 73374914
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=1030836"
      ],
      "otg_id": "GCST006414",
      "neg_log_pval": 35.32039042822024,
      "gwas_catalog_id": "GCST006414",
      "pubmed_id": "30061737"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000138622",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DRONEDARONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000138622 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "15",
        "position": 73374914
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation [EA]",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=537409",
        "East Asian=36792",
        "African American or Afro-Caribbean=8967",
        "Hispanic or Latin American=5022"
      ],
      "otg_id": "GCST006061_3",
      "neg_log_pval": 26.69897000433602,
      "gwas_catalog_id": "GCST006061",
      "pubmed_id": "29892015"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000138622",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DRONEDARONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000138622 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "15",
        "position": 73375705
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation and flutter",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=395739"
      ],
      "otg_id": "SAIGE_427_2",
      "neg_log_pval": 14.522878745280337,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000138622",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DRONEDARONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000138622 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "15",
        "position": 73376665
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=118755"
      ],
      "otg_id": "GCST004297",
      "neg_log_pval": 11.096910013008056,
      "gwas_catalog_id": "GCST004297",
      "pubmed_id": "28416818"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000138622",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DRONEDARONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000138622 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "15",
        "position": 73384923
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=537409",
        "East Asian=36792",
        "African American or Afro-Caribbean=8967",
        "Hispanic or Latin American=5022"
      ],
      "otg_id": "GCST006061",
      "neg_log_pval": 27.0,
      "gwas_catalog_id": "GCST006061",
      "pubmed_id": "29892015"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000138622",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DRONEDARONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000138622 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 27360103
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003785"
      ],
      "reported_trait_name": "Allergic disease (asthma, hay fever or eczema)",
      "standard_trait_name": "allergy"
    },
    "association_info": {
      "ancestry": [
        "European=360838"
      ],
      "otg_id": "GCST005038",
      "neg_log_pval": 7.338092707233979,
      "gwas_catalog_id": "GCST005038",
      "pubmed_id": "29083406"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000077238",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DUPILUMAB is approved for the indication atopic eczema (EFO_0000274) and targets the gene ENSG00000077238 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 27360218
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0000964"
      ],
      "reported_trait_name": "Eczema",
      "standard_trait_name": "Eczema"
    },
    "association_info": {
      "ancestry": [
        "European=459000"
      ],
      "otg_id": "GCST007075",
      "neg_log_pval": 8.096910013008056,
      "gwas_catalog_id": "GCST007075",
      "pubmed_id": "30595370"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000077238",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DUPILUMAB is approved for the indication Eczema (HP_0000964) and targets the gene ENSG00000077238 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 56954132
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000195"
      ],
      "reported_trait_name": "Metabolic syndrome",
      "standard_trait_name": "metabolic syndrome"
    },
    "association_info": {
      "ancestry": [
        "European=22161"
      ],
      "otg_id": "GCST001003",
      "neg_log_pval": 8.045757490560675,
      "gwas_catalog_id": "GCST001003",
      "pubmed_id": "21386085"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000070915",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug HYDROCHLOROTHIAZIDE is approved for the indication metabolic syndrome (EFO_0000195) and targets the gene ENSG00000070915 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 56954132
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000195"
      ],
      "reported_trait_name": "Metabolic syndrome (bivariate traits) [HDLC-WC]",
      "standard_trait_name": "metabolic syndrome"
    },
    "association_info": {
      "ancestry": [
        "European=22161"
      ],
      "otg_id": "GCST001007_4",
      "neg_log_pval": 16.0,
      "gwas_catalog_id": "GCST001007",
      "pubmed_id": "21386085"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000070915",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug HYDROCHLOROTHIAZIDE is approved for the indication metabolic syndrome (EFO_0000195) and targets the gene ENSG00000070915 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 56956804
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000400"
      ],
      "reported_trait_name": "Age-related diseases, mortality and associated endophenotypes",
      "standard_trait_name": "diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=9618"
      ],
      "otg_id": "GCST004045",
      "neg_log_pval": 149.0,
      "gwas_catalog_id": "GCST004045",
      "pubmed_id": "27790247"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000070915",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug HYDROCHLOROTHIAZIDE is approved for the indication diabetes mellitus (EFO_0000400) and targets the gene ENSG00000070915 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 56956804
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000195"
      ],
      "reported_trait_name": "Metabolic syndrome [HDL]",
      "standard_trait_name": "metabolic syndrome"
    },
    "association_info": {
      "ancestry": [
        "European=10564"
      ],
      "otg_id": "GCST001436_2",
      "neg_log_pval": 59.045757490560675,
      "gwas_catalog_id": "GCST001436",
      "pubmed_id": "22399527"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000070915",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug HYDROCHLOROTHIAZIDE is approved for the indication metabolic syndrome (EFO_0000195) and targets the gene ENSG00000070915 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 56959412
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000195"
      ],
      "reported_trait_name": "Metabolic syndrome [HDL]",
      "standard_trait_name": "metabolic syndrome"
    },
    "association_info": {
      "ancestry": [
        "South Asian=2554"
      ],
      "otg_id": "GCST000753_3",
      "neg_log_pval": 48.0,
      "gwas_catalog_id": "GCST000753",
      "pubmed_id": "20694148"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000070915",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug HYDROCHLOROTHIAZIDE is approved for the indication metabolic syndrome (EFO_0000195) and targets the gene ENSG00000070915 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 56959412
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000195"
      ],
      "reported_trait_name": "Metabolic syndrome (bivariate traits) [BP-HDLC]",
      "standard_trait_name": "metabolic syndrome"
    },
    "association_info": {
      "ancestry": [
        "European=22161"
      ],
      "otg_id": "GCST001007_2",
      "neg_log_pval": 12.522878745280337,
      "gwas_catalog_id": "GCST001007",
      "pubmed_id": "21386085"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000070915",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug HYDROCHLOROTHIAZIDE is approved for the indication metabolic syndrome (EFO_0000195) and targets the gene ENSG00000070915 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 56968820
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000195"
      ],
      "reported_trait_name": "Metabolic syndrome (bivariate traits) [HDLC-GLUC]",
      "standard_trait_name": "metabolic syndrome"
    },
    "association_info": {
      "ancestry": [
        "European=22161"
      ],
      "otg_id": "GCST001007_3",
      "neg_log_pval": 11.154901959985743,
      "gwas_catalog_id": "GCST001007",
      "pubmed_id": "21386085"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000070915",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug HYDROCHLOROTHIAZIDE is approved for the indication metabolic syndrome (EFO_0000195) and targets the gene ENSG00000070915 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 89780269
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000311"
      ],
      "reported_trait_name": "Reported occurrences of cancer",
      "standard_trait_name": "cancer"
    },
    "association_info": {
      "ancestry": [
        "European=58607"
      ],
      "otg_id": "NEALE2_40009",
      "neg_log_pval": 11.396639075651619,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000258947",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug VINCRISTINE is approved for the indication cancer (EFO_0000311) and targets the gene ENSG00000258947 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PACLITAXEL is approved for the indication cancer (EFO_0000311) and targets the gene ENSG00000258947 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 89957798
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000311"
      ],
      "reported_trait_name": "Cancer diagnosed by doctor",
      "standard_trait_name": "cancer"
    },
    "association_info": {
      "ancestry": [
        "European=359981"
      ],
      "otg_id": "NEALE2_2453",
      "neg_log_pval": 12.515700160653214,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000258947",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug VINCRISTINE is approved for the indication cancer (EFO_0000311) and targets the gene ENSG00000258947 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PACLITAXEL is approved for the indication cancer (EFO_0000311) and targets the gene ENSG00000258947 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 89960104
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000707"
      ],
      "reported_trait_name": "Squamous cell carcinoma",
      "standard_trait_name": "squamous cell carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=61457"
      ],
      "otg_id": "GCST003327",
      "neg_log_pval": 43.69897000433602,
      "gwas_catalog_id": "GCST003327",
      "pubmed_id": "26829030"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000258947",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DOCETAXEL is approved for the indication squamous cell carcinoma (EFO_0000707) and targets the gene ENSG00000258947 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "16",
        "position": 89961218
      },
      "alleles": {
        "reference": "A",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000707"
      ],
      "reported_trait_name": "Squamous cell carcinoma",
      "standard_trait_name": "squamous cell carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=13550"
      ],
      "otg_id": "GCST003422",
      "neg_log_pval": 8.698970004336019,
      "gwas_catalog_id": "GCST003422",
      "pubmed_id": "26908436"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000258947",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DOCETAXEL is approved for the indication squamous cell carcinoma (EFO_0000707) and targets the gene ENSG00000258947 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "17",
        "position": 43715814
      },
      "alleles": {
        "reference": "CT",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003931"
      ],
      "reported_trait_name": "Fractured/broken bones in last 5 years",
      "standard_trait_name": "bone fracture"
    },
    "association_info": {
      "ancestry": [
        "European=359241"
      ],
      "otg_id": "NEALE2_2463",
      "neg_log_pval": 12.11747546204512,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000167941",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROMOSOZUMAB is approved for the indication bone disease (EFO_0004260) and targets the gene ENSG00000167941 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "17",
        "position": 43721487
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003931"
      ],
      "reported_trait_name": "Fractures",
      "standard_trait_name": "bone fracture"
    },
    "association_info": {
      "ancestry": [
        "European=426795"
      ],
      "otg_id": "GCST006980",
      "neg_log_pval": 40.30102999566398,
      "gwas_catalog_id": "GCST006980",
      "pubmed_id": "30598549"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000167941",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROMOSOZUMAB is approved for the indication bone disease (EFO_0004260) and targets the gene ENSG00000167941 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "17",
        "position": 43749471
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003931"
      ],
      "reported_trait_name": "Fractures",
      "standard_trait_name": "bone fracture"
    },
    "association_info": {
      "ancestry": [
        "East Asian=800",
        "European=264173"
      ],
      "otg_id": "GCST006423",
      "neg_log_pval": 24.522878745280337,
      "gwas_catalog_id": "GCST006423",
      "pubmed_id": "30158200"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000167941",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROMOSOZUMAB is approved for the indication bone disease (EFO_0004260) and targets the gene ENSG00000167941 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "17",
        "position": 63471587
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension | non-cancer illness code, self-reported",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1065",
      "neg_log_pval": 19.50811606596098,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000159640",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BENAZEPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SPIRAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CAPTOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ENALAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug LISINOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug RAMIPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANDOLAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug QUINAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MOEXIPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PERINDOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug FOSINOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "17",
        "position": 63478937
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Essential hypertension",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=408089"
      ],
      "otg_id": "SAIGE_401_1",
      "neg_log_pval": 10.172630726946174,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000159640",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BENAZEPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SPIRAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CAPTOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ENALAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug LISINOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug RAMIPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANDOLAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug QUINAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MOEXIPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PERINDOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug FOSINOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "17",
        "position": 63478937
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=408343"
      ],
      "otg_id": "SAIGE_401",
      "neg_log_pval": 10.26440110030182,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000159640",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BENAZEPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SPIRAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CAPTOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ENALAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug LISINOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug RAMIPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANDOLAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug QUINAPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MOEXIPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PERINDOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug FOSINOPRIL is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "17",
        "position": 63610240
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=655666",
        "South Asian=3650"
      ],
      "otg_id": "GCST006867",
      "neg_log_pval": 7.3979400086720375,
      "gwas_catalog_id": "GCST006867",
      "pubmed_id": "30054458"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000159640",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ENALAPRILAT is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000159640 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "18",
        "position": 63121512
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000095"
      ],
      "reported_trait_name": "Chronic lymphocytic leukemia",
      "standard_trait_name": "chronic lymphocytic leukemia"
    },
    "association_info": {
      "ancestry": [
        "European=17691"
      ],
      "otg_id": "GCST004146",
      "neg_log_pval": 10.698970004336019,
      "gwas_catalog_id": "GCST004146",
      "pubmed_id": "28165464"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000171791",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug VENETOCLAX is approved for the indication chronic lymphocytic leukemia (EFO_0000095) and targets the gene ENSG00000171791 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "18",
        "position": 63126261
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000095"
      ],
      "reported_trait_name": "Chronic lymphocytic leukemia",
      "standard_trait_name": "chronic lymphocytic leukemia"
    },
    "association_info": {
      "ancestry": [
        "European=10767"
      ],
      "otg_id": "GCST003468",
      "neg_log_pval": 10.397940008672037,
      "gwas_catalog_id": "GCST003468",
      "pubmed_id": "26956414"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000171791",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug VENETOCLAX is approved for the indication chronic lymphocytic leukemia (EFO_0000095) and targets the gene ENSG00000171791 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "18",
        "position": 63126316
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000095"
      ],
      "reported_trait_name": "Chronic lymphocytic leukemia",
      "standard_trait_name": "chronic lymphocytic leukemia"
    },
    "association_info": {
      "ancestry": [
        "European=8400"
      ],
      "otg_id": "GCST002073",
      "neg_log_pval": 11.522878745280337,
      "gwas_catalog_id": "GCST002073",
      "pubmed_id": "23770605"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000171791",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug VENETOCLAX is approved for the indication chronic lymphocytic leukemia (EFO_0000095) and targets the gene ENSG00000171791 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "18",
        "position": 63126688
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000095"
      ],
      "reported_trait_name": "Chronic lymphocytic leukemia",
      "standard_trait_name": "chronic lymphocytic leukemia"
    },
    "association_info": {
      "ancestry": [
        "European=8400"
      ],
      "otg_id": "GCST002073",
      "neg_log_pval": 10.096910013008056,
      "gwas_catalog_id": "GCST002073",
      "pubmed_id": "23770605"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000171791",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug VENETOCLAX is approved for the indication chronic lymphocytic leukemia (EFO_0000095) and targets the gene ENSG00000171791 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "19",
        "position": 10631494
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003885"
      ],
      "reported_trait_name": "Multiple sclerosis",
      "standard_trait_name": "multiple sclerosis"
    },
    "association_info": {
      "ancestry": [
        "European=38582"
      ],
      "otg_id": "GCST005531",
      "neg_log_pval": 9.019088062223156,
      "gwas_catalog_id": "GCST005531",
      "pubmed_id": "24076602"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000079999",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DIMETHYL FUMARATE is approved for the indication multiple sclerosis (EFO_0003885) and targets the gene ENSG00000079999 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 1403856
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0005140"
      ],
      "reported_trait_name": "Autoimmune traits",
      "standard_trait_name": "autoimmune disease"
    },
    "association_info": {
      "ancestry": [
        "European=459000"
      ],
      "otg_id": "GCST007071",
      "neg_log_pval": 8.522878745280337,
      "gwas_catalog_id": "GCST007071",
      "pubmed_id": "30595370"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000115705",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METHIMAZOLE is approved for the indication Graves disease (EFO_0004237) and targets the gene ENSG00000115705 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 25406569
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000095"
      ],
      "reported_trait_name": "B-cell malignancies (chronic lymphocytic leukemia, Hodgkin lymphoma or multiple myeloma) (pleiotropy)",
      "standard_trait_name": "chronic lymphocytic leukemia"
    },
    "association_info": {
      "ancestry": [
        "European=14421"
      ],
      "otg_id": "GCST004099",
      "neg_log_pval": 9.221848749616356,
      "gwas_catalog_id": "GCST004099",
      "pubmed_id": "28112199"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000119772",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DECITABINE is approved for the indication lymphoid leukemia (EFO_0004289) and targets the gene ENSG00000119772 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 26691496
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Essential hypertension",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=408089"
      ],
      "otg_id": "SAIGE_401_1",
      "neg_log_pval": 35.59516628338006,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000171303",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SEVOFLURANE is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000171303 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 26691496
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension | non-cancer illness code, self-reported",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1065",
      "neg_log_pval": 39.522019692388156,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000171303",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SEVOFLURANE is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000171303 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 26697157
      },
      "alleles": {
        "reference": "T",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension [Japanese]",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "East Asian=50792"
      ],
      "otg_id": "GCST007707_2",
      "neg_log_pval": 13.301029995663981,
      "gwas_catalog_id": "GCST007707",
      "pubmed_id": "30487518"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000171303",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SEVOFLURANE is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000171303 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 26700700
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "European=408343"
      ],
      "otg_id": "SAIGE_401",
      "neg_log_pval": 35.37263414340727,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000171303",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SEVOFLURANE is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000171303 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 26707543
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000537"
      ],
      "reported_trait_name": "Hypertension [East Asian]",
      "standard_trait_name": "hypertension"
    },
    "association_info": {
      "ancestry": [
        "East Asian=50792"
      ],
      "otg_id": "GCST007707",
      "neg_log_pval": 17.69897000433602,
      "gwas_catalog_id": "GCST007707",
      "pubmed_id": "30487518"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000171303",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SEVOFLURANE is approved for the indication hypertension (EFO_0000537) and targets the gene ENSG00000171303 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 31580756
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0004191"
      ],
      "reported_trait_name": "Male-pattern baldness",
      "standard_trait_name": "androgenetic alopecia"
    },
    "association_info": {
      "ancestry": [
        "European=17500"
      ],
      "otg_id": "GCST003983",
      "neg_log_pval": 14.698970004336019,
      "gwas_catalog_id": "GCST003983",
      "pubmed_id": "27182965"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000277893",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug FINASTERIDE is approved for the indication androgenetic alopecia (EFO_0004191) and targets the gene ENSG00000277893 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 31759341
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "Orphanet_79364"
      ],
      "reported_trait_name": "Male-pattern baldness",
      "standard_trait_name": "Alopecia"
    },
    "association_info": {
      "ancestry": [
        "European=52874"
      ],
      "otg_id": "GCST006661",
      "neg_log_pval": 8.133324037880183,
      "gwas_catalog_id": "GCST006661",
      "pubmed_id": "28196072"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000277893",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug FINASTERIDE is approved for the indication androgenetic alopecia (EFO_0004191) and targets the gene ENSG00000277893 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 136287660
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=455607"
      ],
      "otg_id": "GCST006868",
      "neg_log_pval": 8.0,
      "gwas_catalog_id": "GCST006868",
      "pubmed_id": "30054458"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000121966",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PLERIXAFOR is approved for the indication diabetes mellitus (EFO_0000400) and targets the gene ENSG00000121966 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 156254801
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003761"
      ],
      "reported_trait_name": "Depression",
      "standard_trait_name": "unipolar depression"
    },
    "association_info": {
      "ancestry": [
        "NR=361315",
        "European=446238"
      ],
      "otg_id": "GCST007342",
      "neg_log_pval": 17.522878745280337,
      "gwas_catalog_id": "GCST007342",
      "pubmed_id": "30718901"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000115159",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METFORMIN is approved for the indication unipolar depression (EFO_0003761) and targets the gene ENSG00000115159 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 156254801
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003761"
      ],
      "reported_trait_name": "Depression",
      "standard_trait_name": "unipolar depression"
    },
    "association_info": {
      "ancestry": [
        "European=480359"
      ],
      "otg_id": "GCST005839",
      "neg_log_pval": 7.698970004336019,
      "gwas_catalog_id": "GCST005839",
      "pubmed_id": "29700475"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000115159",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METFORMIN is approved for the indication unipolar depression (EFO_0003761) and targets the gene ENSG00000115159 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 181443625
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003767"
      ],
      "reported_trait_name": "Inflammatory bowel disease",
      "standard_trait_name": "inflammatory bowel disease"
    },
    "association_info": {
      "ancestry": [
        "NR, European=59957"
      ],
      "otg_id": "GCST004131",
      "neg_log_pval": 12.913640169325252,
      "gwas_catalog_id": "GCST004131",
      "pubmed_id": "28067908"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000115232",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NATALIZUMAB is approved for the indication Crohn's disease (EFO_0000384) and targets the gene ENSG00000115232 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "2",
        "position": 181443625
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000384"
      ],
      "reported_trait_name": "Crohn's disease",
      "standard_trait_name": "Crohn's disease"
    },
    "association_info": {
      "ancestry": [
        "European, NR=40266"
      ],
      "otg_id": "GCST004132",
      "neg_log_pval": 10.012333735073724,
      "gwas_catalog_id": "GCST004132",
      "pubmed_id": "28067908"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000115232",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug NATALIZUMAB is approved for the indication Crohn's disease (EFO_0000384) and targets the gene ENSG00000115232 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44209910
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000384"
      ],
      "reported_trait_name": "Crohn's disease [EA]",
      "standard_trait_name": "Crohn's disease"
    },
    "association_info": {
      "ancestry": [
        "European=20883"
      ],
      "otg_id": "GCST003044",
      "neg_log_pval": 9.077580264223702,
      "gwas_catalog_id": "GCST003044",
      "pubmed_id": "26192919"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44436388
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000729"
      ],
      "reported_trait_name": "Ulcerative colitis | non-cancer illness code, self-reported",
      "standard_trait_name": "ulcerative colitis"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1463",
      "neg_log_pval": 8.024100141069358,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44436388
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003767"
      ],
      "reported_trait_name": "Inflammatory bowel disease and other gastroenteritis and colitis",
      "standard_trait_name": "inflammatory bowel disease"
    },
    "association_info": {
      "ancestry": [
        "European=339311"
      ],
      "otg_id": "SAIGE_555",
      "neg_log_pval": 11.020907099361674,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44436388
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000729"
      ],
      "reported_trait_name": "Ulcerative colitis",
      "standard_trait_name": "ulcerative colitis"
    },
    "association_info": {
      "ancestry": [
        "European=337978"
      ],
      "otg_id": "SAIGE_555_2",
      "neg_log_pval": 9.84163750790475,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44436388
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000729"
      ],
      "reported_trait_name": "Ulcerative colitis",
      "standard_trait_name": "ulcerative colitis"
    },
    "association_info": {
      "ancestry": [
        "European, NR=45975"
      ],
      "otg_id": "GCST004133",
      "neg_log_pval": 29.40318306408441,
      "gwas_catalog_id": "GCST004133",
      "pubmed_id": "28067908"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44436388
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000729"
      ],
      "reported_trait_name": "Ulcerative colitis",
      "standard_trait_name": "ulcerative colitis"
    },
    "association_info": {
      "ancestry": [
        "European=34366"
      ],
      "otg_id": "GCST001728",
      "neg_log_pval": 42.84466396253494,
      "gwas_catalog_id": "GCST001728",
      "pubmed_id": "23128233"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44436388
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003767"
      ],
      "reported_trait_name": "Inflammatory bowel disease",
      "standard_trait_name": "inflammatory bowel disease"
    },
    "association_info": {
      "ancestry": [
        "NR, European=59957"
      ],
      "otg_id": "GCST004131",
      "neg_log_pval": 16.970210529168146,
      "gwas_catalog_id": "GCST004131",
      "pubmed_id": "28067908"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44436388
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003767"
      ],
      "reported_trait_name": "Inflammatory bowel disease",
      "standard_trait_name": "inflammatory bowel disease"
    },
    "association_info": {
      "ancestry": [
        "European=34366"
      ],
      "otg_id": "GCST001725",
      "neg_log_pval": 20.844663962534938,
      "gwas_catalog_id": "GCST001725",
      "pubmed_id": "23128233"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44436388
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000729"
      ],
      "reported_trait_name": "Ulcerative colitis",
      "standard_trait_name": "ulcerative colitis"
    },
    "association_info": {
      "ancestry": [
        "European=7778"
      ],
      "otg_id": "GCST000527",
      "neg_log_pval": 16.045757490560675,
      "gwas_catalog_id": "GCST000527",
      "pubmed_id": "19915572"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44436388
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000729"
      ],
      "reported_trait_name": "Ulcerative colitis",
      "standard_trait_name": "ulcerative colitis"
    },
    "association_info": {
      "ancestry": [
        "European=26405"
      ],
      "otg_id": "GCST000964",
      "neg_log_pval": 19.962573502059378,
      "gwas_catalog_id": "GCST000964",
      "pubmed_id": "21297633"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44440356
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000729"
      ],
      "reported_trait_name": "Chronic inflammatory diseases (ankylosing spondylitis, Crohn's disease, psoriasis, primary sclerosing cholangitis, ulcerative colitis) (pleiotropy) [subset analysis]",
      "standard_trait_name": "ulcerative colitis"
    },
    "association_info": {
      "ancestry": [
        "European=86475"
      ],
      "otg_id": "GCST005537",
      "neg_log_pval": 15.154901959985743,
      "gwas_catalog_id": "GCST005537",
      "pubmed_id": "26974007"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 44440356
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000729"
      ],
      "reported_trait_name": "Ulcerative colitis [EA]",
      "standard_trait_name": "ulcerative colitis"
    },
    "association_info": {
      "ancestry": [
        "European=27432"
      ],
      "otg_id": "GCST003045",
      "neg_log_pval": 15.727959387742187,
      "gwas_catalog_id": "GCST003045",
      "pubmed_id": "26192919"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101076",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALVERINE is approved for the indication irritable bowel syndrome (EFO_0000555) and targets the gene ENSG00000101076 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 59084069
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=89677"
      ],
      "otg_id": "GCST007236",
      "neg_log_pval": 7.5130894413060085,
      "gwas_catalog_id": "GCST007236",
      "pubmed_id": "25751625"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101162",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ERIBULIN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000101162 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug IXABEPILONE is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000101162 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRASTUZUMAB EMTANSINE is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000101162 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DOCETAXEL is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000101162 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug VINORELBINE is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000101162 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PACLITAXEL is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000101162 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "20",
        "position": 59138970
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=296525"
      ],
      "otg_id": "GCST005194",
      "neg_log_pval": 9.099086932262331,
      "gwas_catalog_id": "GCST005194",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000101162",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug COLCHICINE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000101162 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PACLITAXEL is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000101162 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12269274
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0005140"
      ],
      "reported_trait_name": "Autoimmune traits",
      "standard_trait_name": "autoimmune disease"
    },
    "association_info": {
      "ancestry": [
        "European=459000"
      ],
      "otg_id": "GCST007071",
      "neg_log_pval": 10.0,
      "gwas_catalog_id": "GCST007071",
      "pubmed_id": "30595370"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication inflammatory bowel disease (EFO_0003767) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12288284
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=459000"
      ],
      "otg_id": "GCST007077",
      "neg_log_pval": 11.0,
      "gwas_catalog_id": "GCST007077",
      "pubmed_id": "30595370"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12288284
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000400"
      ],
      "reported_trait_name": "Diabetes diagnosed by doctor",
      "standard_trait_name": "diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=360192"
      ],
      "otg_id": "NEALE2_2443",
      "neg_log_pval": 7.5486127463375,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication diabetes mellitus (EFO_0000400) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication diabetes mellitus (EFO_0000400) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TROGLITAZONE is approved for the indication diabetes mellitus (EFO_0000400) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12350773
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=69033"
      ],
      "otg_id": "GCST005047",
      "neg_log_pval": 8.795880017344075,
      "gwas_catalog_id": "GCST005047",
      "pubmed_id": "22885922"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12351626
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes (adjusted for BMI)",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=298957"
      ],
      "otg_id": "GCST007518",
      "neg_log_pval": 16.0,
      "gwas_catalog_id": "GCST007518",
      "pubmed_id": "29632382"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12351626
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=298957",
        "South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin American=153287"
      ],
      "otg_id": "GCST007515",
      "neg_log_pval": 17.0,
      "gwas_catalog_id": "GCST007515",
      "pubmed_id": "29632382"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12351626
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes [EA]",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "South Asian=13532",
        "European=20298",
        "NR=149821"
      ],
      "otg_id": "GCST004894_2",
      "neg_log_pval": 13.698970004336019,
      "gwas_catalog_id": "GCST004894",
      "pubmed_id": "28869590"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12351626
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "South Asian=13532",
        "European=20298",
        "NR=149821"
      ],
      "otg_id": "GCST004894",
      "neg_log_pval": 18.69897000433602,
      "gwas_catalog_id": "GCST004894",
      "pubmed_id": "28869590"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12351626
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=298957"
      ],
      "otg_id": "GCST007517",
      "neg_log_pval": 11.301029995663981,
      "gwas_catalog_id": "GCST007517",
      "pubmed_id": "29632382"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12351626
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=69033",
        "East Asian=18817",
        "South Asian=20019",
        "Hispanic or Latin American=2583"
      ],
      "otg_id": "GCST002352",
      "neg_log_pval": 9.221848749616356,
      "gwas_catalog_id": "GCST002352",
      "pubmed_id": "24509480"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12351626
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes (adjusted for BMI)",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=298957",
        "South Asian, East Asian, African American or Afro-Caribbean, Hispanic or Latin American=153287"
      ],
      "otg_id": "GCST007516",
      "neg_log_pval": 18.522878745280337,
      "gwas_catalog_id": "GCST007516",
      "pubmed_id": "29632382"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12353341
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=655666",
        "South Asian=3650"
      ],
      "otg_id": "GCST006867",
      "neg_log_pval": 23.69897000433602,
      "gwas_catalog_id": "GCST006867",
      "pubmed_id": "30054458"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 12355414
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "European=70127"
      ],
      "otg_id": "GCST005413",
      "neg_log_pval": 15.357832365595055,
      "gwas_catalog_id": "GCST005413",
      "pubmed_id": "29358691"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000132170",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PIOGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSIGLITAZONE is approved for the indication type II diabetes mellitus (EFO_0001360) and targets the gene ENSG00000132170 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 52594040
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000692"
      ],
      "reported_trait_name": "Schizophrenia",
      "standard_trait_name": "schizophrenia"
    },
    "association_info": {
      "ancestry": [
        "East Asian=26026",
        "European=82315"
      ],
      "otg_id": "GCST004946",
      "neg_log_pval": 12.301029995663981,
      "gwas_catalog_id": "GCST004946",
      "pubmed_id": "28991256"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000010322",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MOXONIDINE is approved for the indication schizophrenia (EFO_0000692) and targets the gene ENSG00000010322 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 52594040
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000692"
      ],
      "reported_trait_name": "Schizophrenia",
      "standard_trait_name": "schizophrenia"
    },
    "association_info": {
      "ancestry": [
        "East Asian=45528"
      ],
      "otg_id": "GCST007201",
      "neg_log_pval": 12.698970004336019,
      "gwas_catalog_id": "GCST007201",
      "pubmed_id": "30285260"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000010322",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MOXONIDINE is approved for the indication schizophrenia (EFO_0000692) and targets the gene ENSG00000010322 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 119431242
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1001486"
      ],
      "reported_trait_name": "Primary biliary cholangitis",
      "standard_trait_name": "primary biliary cirrhosis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5158"
      ],
      "otg_id": "GCST004302",
      "neg_log_pval": 12.522878745280337,
      "gwas_catalog_id": "GCST004302",
      "pubmed_id": "28425483"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000121594",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABATACEPT is approved for the indication primary biliary cirrhosis (EFO_1001486) and targets the gene ENSG00000121594 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 119501087
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1001486"
      ],
      "reported_trait_name": "Primary biliary cholangitis",
      "standard_trait_name": "primary biliary cirrhosis"
    },
    "association_info": {
      "ancestry": [
        "European=13239"
      ],
      "otg_id": "GCST003129",
      "neg_log_pval": 14.397940008672037,
      "gwas_catalog_id": "GCST003129",
      "pubmed_id": "26394269"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000121594",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABATACEPT is approved for the indication primary biliary cirrhosis (EFO_1001486) and targets the gene ENSG00000121594 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 119501087
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1001486"
      ],
      "reported_trait_name": "Primary biliary cirrhosis",
      "standard_trait_name": "primary biliary cirrhosis"
    },
    "association_info": {
      "ancestry": [
        "European=11375"
      ],
      "otg_id": "GCST005581",
      "neg_log_pval": 15.16526148109616,
      "gwas_catalog_id": "GCST005581",
      "pubmed_id": "22961000"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000121594",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABATACEPT is approved for the indication primary biliary cirrhosis (EFO_1001486) and targets the gene ENSG00000121594 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 119501087
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0004267"
      ],
      "reported_trait_name": "Primary biliary cholangitis",
      "standard_trait_name": "biliary liver cirrhosis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=963"
      ],
      "otg_id": "GCST001685",
      "neg_log_pval": 8.522878745280337,
      "gwas_catalog_id": "GCST001685",
      "pubmed_id": "23000144"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000121594",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABATACEPT is approved for the indication primary biliary cirrhosis (EFO_1001486) and targets the gene ENSG00000121594 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 119501087
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1001486"
      ],
      "reported_trait_name": "Primary biliary cholangitis",
      "standard_trait_name": "primary biliary cirrhosis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=3574"
      ],
      "otg_id": "GCST007036",
      "neg_log_pval": 8.221848749616356,
      "gwas_catalog_id": "GCST007036",
      "pubmed_id": "30643196"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000121594",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABATACEPT is approved for the indication primary biliary cirrhosis (EFO_1001486) and targets the gene ENSG00000121594 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 119501087
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0004267"
      ],
      "reported_trait_name": "Primary biliary cholangitis",
      "standard_trait_name": "biliary liver cirrhosis"
    },
    "association_info": {
      "ancestry": [
        "European=7003"
      ],
      "otg_id": "GCST001010",
      "neg_log_pval": 10.522878745280337,
      "gwas_catalog_id": "GCST001010",
      "pubmed_id": "21399635"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000121594",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABATACEPT is approved for the indication primary biliary cirrhosis (EFO_1001486) and targets the gene ENSG00000121594 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "3",
        "position": 122238106
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001360"
      ],
      "reported_trait_name": "Type 2 diabetes",
      "standard_trait_name": "type II diabetes mellitus"
    },
    "association_info": {
      "ancestry": [
        "East Asian=191764"
      ],
      "otg_id": "GCST007847",
      "neg_log_pval": 8.301029995663981,
      "gwas_catalog_id": "GCST007847",
      "pubmed_id": "30718926"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000114013",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BELATACEPT is approved for the indication diabetes mellitus (EFO_0000400) and targets the gene ENSG00000114013 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "4",
        "position": 148016386
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=537409",
        "East Asian=36792",
        "African American or Afro-Caribbean=8967",
        "Hispanic or Latin American=5022"
      ],
      "otg_id": "GCST006061",
      "neg_log_pval": 13.221848749616356,
      "gwas_catalog_id": "GCST006061",
      "pubmed_id": "29892015"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000151623",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CANRENONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000151623 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SPIRONOLACTONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000151623 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "4",
        "position": 148016386
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=1030836"
      ],
      "otg_id": "GCST006414",
      "neg_log_pval": 10.878440155812498,
      "gwas_catalog_id": "GCST006414",
      "pubmed_id": "30061737"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000151623",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CANRENONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000151623 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SPIRONOLACTONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000151623 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "4",
        "position": 148025539
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation [EA]",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=537409",
        "East Asian=36792",
        "African American or Afro-Caribbean=8967",
        "Hispanic or Latin American=5022"
      ],
      "otg_id": "GCST006061_3",
      "neg_log_pval": 12.154901959985743,
      "gwas_catalog_id": "GCST006061",
      "pubmed_id": "29892015"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000151623",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CANRENONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000151623 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SPIRONOLACTONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000151623 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 1286401
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000571"
      ],
      "reported_trait_name": "Lung adenocarcinoma",
      "standard_trait_name": "lung adenocarcinoma"
    },
    "association_info": {
      "ancestry": [
        "East Asian=2904"
      ],
      "otg_id": "GCST000810",
      "neg_log_pval": 10.522878745280337,
      "gwas_catalog_id": "GCST000810",
      "pubmed_id": "20871597"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000142319",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MODAFINIL is approved for the indication non-small cell lung carcinoma (EFO_0003060) and targets the gene ENSG00000142319 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 1286401
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000571"
      ],
      "reported_trait_name": "Lung adenocarcinoma",
      "standard_trait_name": "lung adenocarcinoma"
    },
    "association_info": {
      "ancestry": [
        "East Asian=1169"
      ],
      "otg_id": "GCST000761",
      "neg_log_pval": 21.69897000433602,
      "gwas_catalog_id": "GCST000761",
      "pubmed_id": "20700438"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000142319",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MODAFINIL is approved for the indication non-small cell lung carcinoma (EFO_0003060) and targets the gene ENSG00000142319 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 1299098
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "MONDO_0000376"
      ],
      "reported_trait_name": "Cancer within the respiratory system",
      "standard_trait_name": "respiratory system cancer"
    },
    "association_info": {
      "ancestry": [
        "European=408926"
      ],
      "otg_id": "SAIGE_165",
      "neg_log_pval": 8.473660722610155,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000142319",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MODAFINIL is approved for the indication non-small cell lung carcinoma (EFO_0003060) and targets the gene ENSG00000142319 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 1315545
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001071"
      ],
      "reported_trait_name": "Lung cancer",
      "standard_trait_name": "lung carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=3390"
      ],
      "otg_id": "GCST000459",
      "neg_log_pval": 8.522878745280337,
      "gwas_catalog_id": "GCST000459",
      "pubmed_id": "19654303"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000142319",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MODAFINIL is approved for the indication non-small cell lung carcinoma (EFO_0003060) and targets the gene ENSG00000142319 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 1321972
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001071"
      ],
      "reported_trait_name": "Lung cancer",
      "standard_trait_name": "lung carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=10295"
      ],
      "otg_id": "GCST000257",
      "neg_log_pval": 8.096910013008056,
      "gwas_catalog_id": "GCST000257",
      "pubmed_id": "18978787"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000142319",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MODAFINIL is approved for the indication non-small cell lung carcinoma (EFO_0003060) and targets the gene ENSG00000142319 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 1442864
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0004698"
      ],
      "reported_trait_name": "Sleeplessness / insomnia",
      "standard_trait_name": "insomnia"
    },
    "association_info": {
      "ancestry": [
        "European=360738"
      ],
      "otg_id": "NEALE2_1200",
      "neg_log_pval": 7.9587810673873625,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000142319",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug MODAFINIL is approved for the indication insomnia (EFO_0004698) and targets the gene ENSG00000142319 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 75309395
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003774"
      ],
      "reported_trait_name": "Hyperlipidemia",
      "standard_trait_name": "hyperlipidemia"
    },
    "association_info": {
      "ancestry": [
        "European=408878"
      ],
      "otg_id": "SAIGE_272_1",
      "neg_log_pval": 15.436518914605589,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113161",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSUVASTATIN is approved for the indication hyperlipidemia (EFO_0003774) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PITAVASTATIN is approved for the indication hyperlipidemia (EFO_0003774) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SIMVASTATIN is approved for the indication hyperlipidemia (EFO_0003774) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PRAVASTATIN is approved for the indication hyperlipidemia (EFO_0003774) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ATORVASTATIN is approved for the indication hyperlipidemia (EFO_0003774) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 75309395
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "Orphanet_309005"
      ],
      "reported_trait_name": "Disorders of lipoid metabolism",
      "standard_trait_name": "Disorder of lipid metabolism"
    },
    "association_info": {
      "ancestry": [
        "European=408961"
      ],
      "otg_id": "SAIGE_272",
      "neg_log_pval": 15.410050398674292,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113161",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug FLUVASTATIN is approved for the indication Disorder of lipid metabolism (Orphanet_309005) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ATORVASTATIN is approved for the indication Disorder of lipid metabolism (Orphanet_309005) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PITAVASTATIN is approved for the indication Disorder of lipid metabolism (Orphanet_309005) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSUVASTATIN is approved for the indication Disorder of lipid metabolism (Orphanet_309005) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PRAVASTATIN is approved for the indication Disorder of lipid metabolism (Orphanet_309005) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SIMVASTATIN is approved for the indication Disorder of lipid metabolism (Orphanet_309005) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 75309395
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0003124"
      ],
      "reported_trait_name": "Hypercholesterolemia",
      "standard_trait_name": "Hypercholesterolemia"
    },
    "association_info": {
      "ancestry": [
        "European=406276"
      ],
      "otg_id": "SAIGE_272_11",
      "neg_log_pval": 14.154901959985743,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113161",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug FLUVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PITAVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug LOVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PRAVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSUVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SIMVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ATORVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 75360714
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0003124"
      ],
      "reported_trait_name": "High cholesterol | non-cancer illness code, self-reported",
      "standard_trait_name": "Hypercholesterolemia"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1473",
      "neg_log_pval": 42.19124767849288,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113161",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug FLUVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PITAVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug LOVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PRAVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSUVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SIMVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ATORVASTATIN is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 75463358
      },
      "alleles": {
        "reference": "T",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001645"
      ],
      "reported_trait_name": "Age-related diseases, mortality and associated endophenotypes",
      "standard_trait_name": "coronary heart disease"
    },
    "association_info": {
      "ancestry": [
        "European=9618"
      ],
      "otg_id": "GCST004045",
      "neg_log_pval": 7.698970004336019,
      "gwas_catalog_id": "GCST004045",
      "pubmed_id": "27790247"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113161",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SIMVASTATIN is approved for the indication coronary heart disease (EFO_0001645) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ROSUVASTATIN is approved for the indication coronary heart disease (EFO_0001645) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ATORVASTATIN is approved for the indication coronary heart disease (EFO_0001645) and targets the gene ENSG00000113161 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 143270839
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation [EA]",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=537409",
        "East Asian=36792",
        "African American or Afro-Caribbean=8967",
        "Hispanic or Latin American=5022"
      ],
      "otg_id": "GCST006061_3",
      "neg_log_pval": 10.221848749616356,
      "gwas_catalog_id": "GCST006061",
      "pubmed_id": "29892015"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113580",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DEXAMETHASONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000113580 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METHYLPREDNISOLONE HEMISUCCINATE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000113580 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PREDNISONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000113580 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 143270839
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=537409",
        "East Asian=36792",
        "African American or Afro-Caribbean=8967",
        "Hispanic or Latin American=5022"
      ],
      "otg_id": "GCST006061",
      "neg_log_pval": 11.0,
      "gwas_catalog_id": "GCST006061",
      "pubmed_id": "29892015"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113580",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DEXAMETHASONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000113580 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METHYLPREDNISOLONE HEMISUCCINATE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000113580 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PREDNISONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000113580 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 143500967
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=1030836"
      ],
      "otg_id": "GCST006414",
      "neg_log_pval": 16.716472635138306,
      "gwas_catalog_id": "GCST006414",
      "pubmed_id": "30061737"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113580",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DEXAMETHASONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000113580 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug METHYLPREDNISOLONE HEMISUCCINATE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000113580 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PREDNISONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000113580 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159242905
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=33394"
      ],
      "otg_id": "GCST005527",
      "neg_log_pval": 10.388393510619363,
      "gwas_catalog_id": "GCST005527",
      "pubmed_id": "23143594"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159290781
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Cutaneous psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=6297"
      ],
      "otg_id": "GCST003269",
      "neg_log_pval": 13.0,
      "gwas_catalog_id": "GCST003269",
      "pubmed_id": "26626624"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159290781
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=2759"
      ],
      "otg_id": "GCST000322",
      "neg_log_pval": 27.69897000433602,
      "gwas_catalog_id": "GCST000322",
      "pubmed_id": "19169254"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159304540
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0005140"
      ],
      "reported_trait_name": "Autoimmune traits",
      "standard_trait_name": "autoimmune disease"
    },
    "association_info": {
      "ancestry": [
        "European=459000"
      ],
      "otg_id": "GCST007071",
      "neg_log_pval": 7.698970004336019,
      "gwas_catalog_id": "GCST007071",
      "pubmed_id": "30595370"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159322080
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis [EA, conditional on rs7709212, rs4921493]",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5134",
        "European=8682"
      ],
      "otg_id": "GCST002874_6",
      "neg_log_pval": 7.698970004336019,
      "gwas_catalog_id": "GCST002874",
      "pubmed_id": "25903422"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159322080
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis [conditional on rs7709212, rs4921493]",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5134",
        "European=8682"
      ],
      "otg_id": "GCST002874_10",
      "neg_log_pval": 9.301029995663981,
      "gwas_catalog_id": "GCST002874",
      "pubmed_id": "25903422"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159323761
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=2271"
      ],
      "otg_id": "GCST000321",
      "neg_log_pval": 25.522878745280337,
      "gwas_catalog_id": "GCST000321",
      "pubmed_id": "19169255"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159323761
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=7353"
      ],
      "otg_id": "GCST000833",
      "neg_log_pval": 10.301029995663981,
      "gwas_catalog_id": "GCST000833",
      "pubmed_id": "20953190"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159328837
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003778"
      ],
      "reported_trait_name": "Psoriatic arthropathy",
      "standard_trait_name": "psoriatic arthritis"
    },
    "association_info": {
      "ancestry": [
        "European=398907"
      ],
      "otg_id": "SAIGE_696_42",
      "neg_log_pval": 8.0268721464003,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriatic arthritis (EFO_0003778) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159332892
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Inflammatory skin disease [Psoriasis]",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=18190"
      ],
      "otg_id": "GCST002740_4",
      "neg_log_pval": 34.52287874528034,
      "gwas_catalog_id": "GCST002740",
      "pubmed_id": "25574825"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159332892
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=1618"
      ],
      "otg_id": "GCST000836",
      "neg_log_pval": 20.0,
      "gwas_catalog_id": "GCST000836",
      "pubmed_id": "20953188"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159337169
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1001494"
      ],
      "reported_trait_name": "Psoriasis vulgaris",
      "standard_trait_name": "psoriasis vulgaris"
    },
    "association_info": {
      "ancestry": [
        "European=8941"
      ],
      "otg_id": "GCST003268",
      "neg_log_pval": 41.69897000433602,
      "gwas_catalog_id": "GCST003268",
      "pubmed_id": "26626624"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159337169
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis [Chinese]",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5134",
        "European=8682"
      ],
      "otg_id": "GCST002874_3",
      "neg_log_pval": 11.0,
      "gwas_catalog_id": "GCST002874",
      "pubmed_id": "25903422"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159337169
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis [Chinese, conditional on rs1990760]",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5134",
        "European=8682"
      ],
      "otg_id": "GCST002874_2",
      "neg_log_pval": 8.301029995663981,
      "gwas_catalog_id": "GCST002874",
      "pubmed_id": "25903422"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159337169
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis [EA]",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5134",
        "European=8682"
      ],
      "otg_id": "GCST002874_8",
      "neg_log_pval": 19.522878745280337,
      "gwas_catalog_id": "GCST002874",
      "pubmed_id": "25903422"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159337169
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5134",
        "European=8682"
      ],
      "otg_id": "GCST002874",
      "neg_log_pval": 29.69897000433602,
      "gwas_catalog_id": "GCST002874",
      "pubmed_id": "25903422"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159337470
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003778"
      ],
      "reported_trait_name": "Psoriatic arthritis",
      "standard_trait_name": "psoriatic arthritis"
    },
    "association_info": {
      "ancestry": [
        "European=6880"
      ],
      "otg_id": "GCST003270",
      "neg_log_pval": 24.0,
      "gwas_catalog_id": "GCST003270",
      "pubmed_id": "26626624"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriatic arthritis (EFO_0003778) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159339014
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis | non-cancer illness code, self-reported",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1453",
      "neg_log_pval": 22.400348322298537,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159341357
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003778"
      ],
      "reported_trait_name": "Psoriatic arthritis",
      "standard_trait_name": "psoriatic arthritis"
    },
    "association_info": {
      "ancestry": [
        "European=2198"
      ],
      "otg_id": "GCST007043",
      "neg_log_pval": 9.045757490560675,
      "gwas_catalog_id": "GCST007043",
      "pubmed_id": "30552173"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriatic arthritis (EFO_0003778) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159383785
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis | non-cancer illness code, self-reported",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1453",
      "neg_log_pval": 20.03839715731701,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159393053
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=400436"
      ],
      "otg_id": "SAIGE_696_4",
      "neg_log_pval": 13.292429823902063,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159394909
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=33394"
      ],
      "otg_id": "GCST005527",
      "neg_log_pval": 13.017728766960431,
      "gwas_catalog_id": "GCST005527",
      "pubmed_id": "23143594"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159399302
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1001494"
      ],
      "reported_trait_name": "Psoriasis vulgaris",
      "standard_trait_name": "psoriasis vulgaris"
    },
    "association_info": {
      "ancestry": [
        "European=399883"
      ],
      "otg_id": "SAIGE_696_41",
      "neg_log_pval": 14.522878745280337,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159399302
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis and related disorders",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=400492"
      ],
      "otg_id": "SAIGE_696",
      "neg_log_pval": 20.714442690992225,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159402281
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=400436"
      ],
      "otg_id": "SAIGE_696_4",
      "neg_log_pval": 19.950781977329818,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159402519
      },
      "alleles": {
        "reference": "A",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003778"
      ],
      "reported_trait_name": "Psoriatic arthritis",
      "standard_trait_name": "psoriatic arthritis"
    },
    "association_info": {
      "ancestry": [
        "European=1460"
      ],
      "otg_id": "GCST000835",
      "neg_log_pval": 16.154901959985743,
      "gwas_catalog_id": "GCST000835",
      "pubmed_id": "20953186"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriatic arthritis (EFO_0003778) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159402519
      },
      "alleles": {
        "reference": "A",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=287323"
      ],
      "otg_id": "GCST004346",
      "neg_log_pval": 83.52287874528034,
      "gwas_catalog_id": "GCST004346",
      "pubmed_id": "28537254"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159402519
      },
      "alleles": {
        "reference": "A",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis | non-cancer illness code, self-reported",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1453",
      "neg_log_pval": 32.77779353908738,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159402519
      },
      "alleles": {
        "reference": "A",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003778"
      ],
      "reported_trait_name": "Psoriatic arthropathy | non-cancer illness code, self-reported",
      "standard_trait_name": "psoriatic arthritis"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1477",
      "neg_log_pval": 11.735654492949907,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriatic arthritis (EFO_0003778) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159402519
      },
      "alleles": {
        "reference": "A",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "European=33394"
      ],
      "otg_id": "GCST005527",
      "neg_log_pval": 12.669586226650809,
      "gwas_catalog_id": "GCST005527",
      "pubmed_id": "23143594"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159402519
      },
      "alleles": {
        "reference": "A",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003778"
      ],
      "reported_trait_name": "Psoriatic arthropathy",
      "standard_trait_name": "psoriatic arthritis"
    },
    "association_info": {
      "ancestry": [
        "European=398907"
      ],
      "otg_id": "SAIGE_696_42",
      "neg_log_pval": 10.665546248849068,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriatic arthritis (EFO_0003778) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159409099
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis [EA, conditional on rs7709212]",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5134",
        "European=8682"
      ],
      "otg_id": "GCST002874_7",
      "neg_log_pval": 10.522878745280337,
      "gwas_catalog_id": "GCST002874",
      "pubmed_id": "25903422"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "5",
        "position": 159409099
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000676"
      ],
      "reported_trait_name": "Psoriasis [conditional on rs7709212]",
      "standard_trait_name": "psoriasis"
    },
    "association_info": {
      "ancestry": [
        "East Asian=5134",
        "European=8682"
      ],
      "otg_id": "GCST002874_11",
      "neg_log_pval": 12.154901959985743,
      "gwas_catalog_id": "GCST002874",
      "pubmed_id": "25903422"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000113302",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug USTEKINUMAB is approved for the indication psoriasis (EFO_0000676) and targets the gene ENSG00000113302 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 30633455
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001663"
      ],
      "reported_trait_name": "Prostate cancer",
      "standard_trait_name": "prostate carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=140254"
      ],
      "otg_id": "GCST006085",
      "neg_log_pval": 8.221848749616356,
      "gwas_catalog_id": "GCST006085",
      "pubmed_id": "29892016"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000196230",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug CABAZITAXEL is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000196230 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 30914638
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000708"
      ],
      "reported_trait_name": "Squamous cell lung carcinoma",
      "standard_trait_name": "squamous cell lung carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=63053"
      ],
      "otg_id": "GCST004750",
      "neg_log_pval": 15.522878745280337,
      "gwas_catalog_id": "GCST004750",
      "pubmed_id": "28604730"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000196230",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PACLITAXEL is approved for the indication squamous cell lung carcinoma (EFO_0000708) and targets the gene ENSG00000196230 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DOCETAXEL is approved for the indication squamous cell lung carcinoma (EFO_0000708) and targets the gene ENSG00000196230 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 39156672
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Myocardial infarction",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "African American or Afro-Caribbean=2908",
        "Hispanic or Latin American=3615",
        "South Asian=23156",
        "Greater Middle Eastern (Middle Eastern / North African / Persian)=754",
        "East Asian=9396",
        "European=126630"
      ],
      "otg_id": "GCST003117",
      "neg_log_pval": 7.522878745280337,
      "gwas_catalog_id": "GCST003117",
      "pubmed_id": "26343387"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000112164",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EXENATIDE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000112164 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 39166323
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "European=141217",
        "African American or Afro-Caribbean=3139",
        "Hispanic or Latin American=4095",
        "South Asian=25557",
        "Greater Middle Eastern (Middle Eastern / North African / Persian)=2268",
        "East Asian=11323"
      ],
      "otg_id": "GCST003116",
      "neg_log_pval": 7.698970004336019,
      "gwas_catalog_id": "GCST003116",
      "pubmed_id": "26343387"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000112164",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EXENATIDE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000112164 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 39207146
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=296525"
      ],
      "otg_id": "GCST005194",
      "neg_log_pval": 11.117418546445549,
      "gwas_catalog_id": "GCST005194",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000112164",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EXENATIDE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000112164 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 39207146
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=250736"
      ],
      "otg_id": "GCST005196",
      "neg_log_pval": 11.522878745280337,
      "gwas_catalog_id": "GCST005196",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000112164",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EXENATIDE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000112164 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151494876
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001065"
      ],
      "reported_trait_name": "Endometriosis",
      "standard_trait_name": "endometriosis"
    },
    "association_info": {
      "ancestry": [
        "European=204641",
        "East Asian=4262"
      ],
      "otg_id": "GCST004549",
      "neg_log_pval": 7.3979400086720375,
      "gwas_catalog_id": "GCST004549",
      "pubmed_id": "28537267"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ETHINYL ESTRADIOL is approved for the indication endometriosis (EFO_0001065) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151586613
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003931"
      ],
      "reported_trait_name": "Fractures",
      "standard_trait_name": "bone fracture"
    },
    "association_info": {
      "ancestry": [
        "European=426795"
      ],
      "otg_id": "GCST006980",
      "neg_log_pval": 22.69897000433602,
      "gwas_catalog_id": "GCST006980",
      "pubmed_id": "30598549"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ESTRADIOL VALERATE is approved for the indication osteoporosis (EFO_0003882) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151592978
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=22627"
      ],
      "otg_id": "GCST001937",
      "neg_log_pval": 20.69897000433602,
      "gwas_catalog_id": "GCST001937",
      "pubmed_id": "23535729"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151597721
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1000650"
      ],
      "reported_trait_name": "Breast cancer (estrogen-receptor negative)",
      "standard_trait_name": "estrogen-receptor negative breast cancer"
    },
    "association_info": {
      "ancestry": [
        "European=19291"
      ],
      "otg_id": "GCST003842",
      "neg_log_pval": 14.045757490560675,
      "gwas_catalog_id": "GCST003842",
      "pubmed_id": "27117709"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151597721
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=33864"
      ],
      "otg_id": "GCST004950",
      "neg_log_pval": 26.154901959985743,
      "gwas_catalog_id": "GCST004950",
      "pubmed_id": "25751625"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151597721
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=19291"
      ],
      "otg_id": "GCST003845",
      "neg_log_pval": 19.0,
      "gwas_catalog_id": "GCST003845",
      "pubmed_id": "27117709"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151604372
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003761"
      ],
      "reported_trait_name": "Depression",
      "standard_trait_name": "unipolar depression"
    },
    "association_info": {
      "ancestry": [
        "European=688809"
      ],
      "otg_id": "GCST006477",
      "neg_log_pval": 9.154901959985743,
      "gwas_catalog_id": "GCST006477",
      "pubmed_id": "29942085"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ESTRADIOL is approved for the indication unipolar depression (EFO_0003761) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151621059
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast Cancer in BRCA1 mutation carriers",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=15566"
      ],
      "otg_id": "GCST005075",
      "neg_log_pval": 11.522878745280337,
      "gwas_catalog_id": "GCST005075",
      "pubmed_id": "29058716"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151621059
      },
      "alleles": {
        "reference": "T",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1000650"
      ],
      "reported_trait_name": "Breast cancer (estrogen-receptor negative)",
      "standard_trait_name": "estrogen-receptor negative breast cancer"
    },
    "association_info": {
      "ancestry": [
        "European=72261"
      ],
      "otg_id": "GCST005076",
      "neg_log_pval": 30.522878745280337,
      "gwas_catalog_id": "GCST005076",
      "pubmed_id": "29058716"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151623479
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0009443"
      ],
      "reported_trait_name": "BRCA1/2-negative high-risk breast cancer",
      "standard_trait_name": "BRCAX breast cancer"
    },
    "association_info": {
      "ancestry": [
        "East Asian=7448"
      ],
      "otg_id": "GCST006719",
      "neg_log_pval": 10.0,
      "gwas_catalog_id": "GCST006719",
      "pubmed_id": "30323354"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151625017
      },
      "alleles": {
        "reference": "T",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1000650"
      ],
      "reported_trait_name": "Breast cancer (estrogen-receptor negative)",
      "standard_trait_name": "estrogen-receptor negative breast cancer"
    },
    "association_info": {
      "ancestry": [
        "European=19291"
      ],
      "otg_id": "GCST003842",
      "neg_log_pval": 17.096910013008056,
      "gwas_catalog_id": "GCST003842",
      "pubmed_id": "27117709"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151625017
      },
      "alleles": {
        "reference": "T",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=19291"
      ],
      "otg_id": "GCST003845",
      "neg_log_pval": 27.397940008672037,
      "gwas_catalog_id": "GCST003845",
      "pubmed_id": "27117709"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151627231
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "East Asian=3027"
      ],
      "otg_id": "GCST000343",
      "neg_log_pval": 14.698970004336019,
      "gwas_catalog_id": "GCST000343",
      "pubmed_id": "19219042"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151627231
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=39387"
      ],
      "otg_id": "GCST001930",
      "neg_log_pval": 15.301029995663981,
      "gwas_catalog_id": "GCST001930",
      "pubmed_id": "23535733"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151627231
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "East Asian=13905"
      ],
      "otg_id": "GCST003520",
      "neg_log_pval": 14.154901959985743,
      "gwas_catalog_id": "GCST003520",
      "pubmed_id": "27354352"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151627231
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=33864"
      ],
      "otg_id": "GCST004950",
      "neg_log_pval": 23.221848749616356,
      "gwas_catalog_id": "GCST004950",
      "pubmed_id": "25751625"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151627231
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast Cancer in BRCA1 mutation carriers",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=2727"
      ],
      "otg_id": "GCST001916",
      "neg_log_pval": 8.301029995663981,
      "gwas_catalog_id": "GCST001916",
      "pubmed_id": "23544013"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151627231
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0009443"
      ],
      "reported_trait_name": "BRCA1/2-negative high-risk breast cancer",
      "standard_trait_name": "BRCAX breast cancer"
    },
    "association_info": {
      "ancestry": [
        "East Asian=7448"
      ],
      "otg_id": "GCST006719",
      "neg_log_pval": 9.0,
      "gwas_catalog_id": "GCST006719",
      "pubmed_id": "30323354"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151628671
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=401447"
      ],
      "otg_id": "SAIGE_174",
      "neg_log_pval": 15.344861565188618,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151631197
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer | illnesses of mother",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=330828"
      ],
      "otg_id": "NEALE2_20110_5",
      "neg_log_pval": 12.785156151952302,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151631197
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1000650"
      ],
      "reported_trait_name": "Breast cancer (estrogen-receptor negative)",
      "standard_trait_name": "estrogen-receptor negative breast cancer"
    },
    "association_info": {
      "ancestry": [
        "European=72261"
      ],
      "otg_id": "GCST005076",
      "neg_log_pval": 39.52287874528034,
      "gwas_catalog_id": "GCST005076",
      "pubmed_id": "29058716"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151631510
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=139274"
      ],
      "otg_id": "GCST004988",
      "neg_log_pval": 7.895171596346344,
      "gwas_catalog_id": "GCST004988",
      "pubmed_id": "29059683"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151633699
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "Hispanic or Latin American=4710"
      ],
      "otg_id": "GCST002662",
      "neg_log_pval": 17.045757490560675,
      "gwas_catalog_id": "GCST002662",
      "pubmed_id": "25327703"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151634779
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=139274"
      ],
      "otg_id": "GCST004988",
      "neg_log_pval": 53.54668165995296,
      "gwas_catalog_id": "GCST004988",
      "pubmed_id": "29059683"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151666222
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=32530",
        "African American or Afro-Caribbean=3748"
      ],
      "otg_id": "GCST001683",
      "neg_log_pval": 9.698970004336019,
      "gwas_catalog_id": "GCST001683",
      "pubmed_id": "22976474"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151692613
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003931"
      ],
      "reported_trait_name": "Fractures",
      "standard_trait_name": "bone fracture"
    },
    "association_info": {
      "ancestry": [
        "East Asian=800",
        "European=264173"
      ],
      "otg_id": "GCST006423",
      "neg_log_pval": 18.30102999566398,
      "gwas_catalog_id": "GCST006423",
      "pubmed_id": "30158200"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ESTRADIOL VALERATE is approved for the indication osteoporosis (EFO_0003882) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151699255
      },
      "alleles": {
        "reference": "A",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=139274"
      ],
      "otg_id": "GCST004988",
      "neg_log_pval": 18.080451241031152,
      "gwas_catalog_id": "GCST004988",
      "pubmed_id": "29059683"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 151713685
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=401447"
      ],
      "otg_id": "SAIGE_174",
      "neg_log_pval": 7.47755576649368,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 152111767
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=139274"
      ],
      "otg_id": "GCST004988",
      "neg_log_pval": 25.84893674664625,
      "gwas_catalog_id": "GCST004988",
      "pubmed_id": "29059683"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 152115881
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000305"
      ],
      "reported_trait_name": "Breast cancer",
      "standard_trait_name": "breast carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=401447"
      ],
      "otg_id": "SAIGE_174",
      "neg_log_pval": 12.767003889607846,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 152115881
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_1000650"
      ],
      "reported_trait_name": "Breast cancer (estrogen-receptor negative)",
      "standard_trait_name": "estrogen-receptor negative breast cancer"
    },
    "association_info": {
      "ancestry": [
        "European=72261"
      ],
      "otg_id": "GCST005076",
      "neg_log_pval": 17.69897000433602,
      "gwas_catalog_id": "GCST005076",
      "pubmed_id": "29058716"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TAMOXIFEN is approved for the indication breast carcinoma (EFO_0000305) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 152232879
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001065"
      ],
      "reported_trait_name": "Endometriosis",
      "standard_trait_name": "endometriosis"
    },
    "association_info": {
      "ancestry": [
        "European=204641",
        "East Asian=4262"
      ],
      "otg_id": "GCST004549",
      "neg_log_pval": 7.698970004336019,
      "gwas_catalog_id": "GCST004549",
      "pubmed_id": "28537267"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ETHINYL ESTRADIOL is approved for the indication endometriosis (EFO_0001065) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 152232879
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001065"
      ],
      "reported_trait_name": "Endometriosis [EA]",
      "standard_trait_name": "endometriosis"
    },
    "association_info": {
      "ancestry": [
        "European=204641",
        "East Asian=4262"
      ],
      "otg_id": "GCST004549_2",
      "neg_log_pval": 7.698970004336019,
      "gwas_catalog_id": "GCST004549",
      "pubmed_id": "28537267"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000091831",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ETHINYL ESTRADIOL is approved for the indication endometriosis (EFO_0001065) and targets the gene ENSG00000091831 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160541471
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001645"
      ],
      "reported_trait_name": "Coronary heart disease",
      "standard_trait_name": "coronary heart disease"
    },
    "association_info": {
      "ancestry": [
        "European=4864"
      ],
      "otg_id": "GCST000341",
      "neg_log_pval": 14.397940008672037,
      "gwas_catalog_id": "GCST000341",
      "pubmed_id": "19198611"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160548706
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001645"
      ],
      "reported_trait_name": "Coronary heart disease",
      "standard_trait_name": "coronary heart disease"
    },
    "association_info": {
      "ancestry": [
        "European=4864"
      ],
      "otg_id": "GCST000341",
      "neg_log_pval": 14.397940008672037,
      "gwas_catalog_id": "GCST000341",
      "pubmed_id": "19198611"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160576086
      },
      "alleles": {
        "reference": "A",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003777"
      ],
      "reported_trait_name": "Cardiac and circulatory congenital anomalies",
      "standard_trait_name": "heart disease"
    },
    "association_info": {
      "ancestry": [
        "European=408961"
      ],
      "otg_id": "SAIGE_747",
      "neg_log_pval": 8.106793246940152,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication congestive heart failure (EFO_0000373) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160576086
      },
      "alleles": {
        "reference": "A",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003777"
      ],
      "reported_trait_name": "Cardiac congenital anomalies",
      "standard_trait_name": "heart disease"
    },
    "association_info": {
      "ancestry": [
        "European=408783"
      ],
      "otg_id": "SAIGE_747_1",
      "neg_log_pval": 9.013228265733755,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication congestive heart failure (EFO_0000373) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160584578
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "European=141217",
        "African American or Afro-Caribbean=3139",
        "Hispanic or Latin American=4095",
        "South Asian=25557",
        "Greater Middle Eastern (Middle Eastern / North African / Persian)=2268",
        "East Asian=11323"
      ],
      "otg_id": "GCST003116",
      "neg_log_pval": 38.30102999566398,
      "gwas_catalog_id": "GCST003116",
      "pubmed_id": "26343387"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160584578
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "MONDO_0021661"
      ],
      "reported_trait_name": "Coronary atherosclerosis",
      "standard_trait_name": "coronary atherosclerosis"
    },
    "association_info": {
      "ancestry": [
        "European=397126"
      ],
      "otg_id": "SAIGE_411_4",
      "neg_log_pval": 72.014573525917,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160584578
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=250736"
      ],
      "otg_id": "GCST005196",
      "neg_log_pval": 153.52287874528034,
      "gwas_catalog_id": "GCST005196",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160584578
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=296525"
      ],
      "otg_id": "GCST005194",
      "neg_log_pval": 153.0096611452124,
      "gwas_catalog_id": "GCST005194",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160584578
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Heart attack/myocardial infarction | non-cancer illness code, self-reported",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1075",
      "neg_log_pval": 28.71524000401907,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TENECTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160584578
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=547261"
      ],
      "otg_id": "GCST005195",
      "neg_log_pval": 119.20065945054642,
      "gwas_catalog_id": "GCST005195",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160584578
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Myocardial infarction",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "European=388806"
      ],
      "otg_id": "SAIGE_411_2",
      "neg_log_pval": 40.28149831113272,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TENECTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160584578
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Ischemic heart disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "European=408458"
      ],
      "otg_id": "SAIGE_411",
      "neg_log_pval": 61.367542707815275,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160585045
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=250736"
      ],
      "otg_id": "GCST005196",
      "neg_log_pval": 10.522878745280337,
      "gwas_catalog_id": "GCST005196",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160585045
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=250736"
      ],
      "otg_id": "GCST005196",
      "neg_log_pval": 10.522878745280337,
      "gwas_catalog_id": "GCST005196",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160589086
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Heart attack | vascular/heart problems diagnosed by doctor",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "European=360420"
      ],
      "otg_id": "NEALE2_6150_1",
      "neg_log_pval": 27.967377210462196,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TENECTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160589086
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000266"
      ],
      "reported_trait_name": "Aortic valve stenosis",
      "standard_trait_name": "aortic valve stenosis"
    },
    "association_info": {
      "ancestry": [
        "European=351799"
      ],
      "otg_id": "GCST005561",
      "neg_log_pval": 30.69897000433602,
      "gwas_catalog_id": "GCST005561",
      "pubmed_id": "29511194"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160589086
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Myocardial infarction",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "African American or Afro-Caribbean=2908",
        "Hispanic or Latin American=3615",
        "South Asian=23156",
        "Greater Middle Eastern (Middle Eastern / North African / Persian)=754",
        "East Asian=9396",
        "European=126630"
      ],
      "otg_id": "GCST003117",
      "neg_log_pval": 26.045757490560675,
      "gwas_catalog_id": "GCST003117",
      "pubmed_id": "26343387"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TENECTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160589086
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease)",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "European, NR=63731"
      ],
      "otg_id": "GCST004787",
      "neg_log_pval": 48.69897000433602,
      "gwas_catalog_id": "GCST004787",
      "pubmed_id": "28714975"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160589086
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003914"
      ],
      "reported_trait_name": "Atherosclerosis",
      "standard_trait_name": "atherosclerosis"
    },
    "association_info": {
      "ancestry": [
        "European=401919"
      ],
      "otg_id": "SAIGE_440",
      "neg_log_pval": 9.10292299679058,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160589086
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000712"
      ],
      "reported_trait_name": "Coronary artery disease or ischemic stroke",
      "standard_trait_name": "cerebrovascular accident"
    },
    "association_info": {
      "ancestry": [
        "NR=123388"
      ],
      "otg_id": "GCST002287",
      "neg_log_pval": 11.698970004336019,
      "gwas_catalog_id": "GCST002287",
      "pubmed_id": "24262325"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication cerebrovascular accident (EFO_0000712) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160591981
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Heart attack/myocardial infarction | non-cancer illness code, self-reported",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1075",
      "neg_log_pval": 17.90926593057954,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TENECTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160591981
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "MONDO_0021661"
      ],
      "reported_trait_name": "Coronary atherosclerosis",
      "standard_trait_name": "coronary atherosclerosis"
    },
    "association_info": {
      "ancestry": [
        "European=397126"
      ],
      "otg_id": "SAIGE_411_4",
      "neg_log_pval": 52.04095860767891,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160591981
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=547261"
      ],
      "otg_id": "GCST005195",
      "neg_log_pval": 76.85387196432177,
      "gwas_catalog_id": "GCST005195",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160591981
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Myocardial infarction",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "European=388806"
      ],
      "otg_id": "SAIGE_411_2",
      "neg_log_pval": 25.059981844992336,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TENECTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160591981
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Ischemic heart disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "European=408458"
      ],
      "otg_id": "SAIGE_411",
      "neg_log_pval": 42.36957212497498,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160596331
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=296525"
      ],
      "otg_id": "GCST005194",
      "neg_log_pval": 9.409046764812015,
      "gwas_catalog_id": "GCST005194",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160666831
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=250736"
      ],
      "otg_id": "GCST005196",
      "neg_log_pval": 7.698970004336019,
      "gwas_catalog_id": "GCST005196",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160687112
      },
      "alleles": {
        "reference": "C",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Myocardial infarction",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "African American or Afro-Caribbean=2908",
        "Hispanic or Latin American=3615",
        "South Asian=23156",
        "Greater Middle Eastern (Middle Eastern / North African / Persian)=754",
        "East Asian=9396",
        "European=126630"
      ],
      "otg_id": "GCST003117",
      "neg_log_pval": 23.69897000433602,
      "gwas_catalog_id": "GCST003117",
      "pubmed_id": "26343387"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TENECTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160690668
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Heart attack | vascular/heart problems diagnosed by doctor",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "European=360420"
      ],
      "otg_id": "NEALE2_6150_1",
      "neg_log_pval": 17.657683931817257,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ALTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TENECTEPLASE is approved for the indication myocardial infarction (EFO_0000612) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160690668
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=296525"
      ],
      "otg_id": "GCST005194",
      "neg_log_pval": 96.70114692359029,
      "gwas_catalog_id": "GCST005194",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160690668
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "NR=250736"
      ],
      "otg_id": "GCST005196",
      "neg_log_pval": 91.30102999566398,
      "gwas_catalog_id": "GCST005196",
      "pubmed_id": "29212778"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "6",
        "position": 160702419
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000378"
      ],
      "reported_trait_name": "Coronary artery disease",
      "standard_trait_name": "coronary artery disease"
    },
    "association_info": {
      "ancestry": [
        "European=141217",
        "African American or Afro-Caribbean=3139",
        "Hispanic or Latin American=4095",
        "South Asian=25557",
        "Greater Middle Eastern (Middle Eastern / North African / Persian)=2268",
        "East Asian=11323"
      ],
      "otg_id": "GCST003116",
      "neg_log_pval": 31.69897000433602,
      "gwas_catalog_id": "GCST003116",
      "pubmed_id": "26343387"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000122194",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug UROKINASE is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug TRANEXAMIC ACID is approved for the indication coronary artery disease (EFO_0000378) and targets the gene ENSG00000122194 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "7",
        "position": 44544952
      },
      "alleles": {
        "reference": "G",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0003124"
      ],
      "reported_trait_name": "High cholesterol | non-cancer illness code, self-reported",
      "standard_trait_name": "Hypercholesterolemia"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1473",
      "neg_log_pval": 14.154901959985743,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000015520",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug EZETIMIBE is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000015520 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "7",
        "position": 100701361
      },
      "alleles": {
        "reference": "A",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000692"
      ],
      "reported_trait_name": "Pursuit maintenance gain in psychotic disorders [African]",
      "standard_trait_name": "schizophrenia"
    },
    "association_info": {
      "ancestry": [
        "African unspecified=224",
        "European=367"
      ],
      "otg_id": "GCST005028_2",
      "neg_log_pval": 8.0,
      "gwas_catalog_id": "GCST005028",
      "pubmed_id": "29064472"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000087085",
      "evidence": [
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug GALANTAMINE is approved for the indication schizophrenia (EFO_0000692) and targets the gene ENSG00000087085 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "Medium",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DONEPEZIL is approved for the indication schizophrenia (EFO_0000692) and targets the gene ENSG00000087085 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "7",
        "position": 150964321
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=1030836"
      ],
      "otg_id": "GCST006414",
      "neg_log_pval": 10.674484336636851,
      "gwas_catalog_id": "GCST006414",
      "pubmed_id": "30061737"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000055118",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SOTALOL is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug IBUTILIDE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DOFETILIDE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug AMIODARONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "7",
        "position": 150964321
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=537409",
        "East Asian=36792",
        "African American or Afro-Caribbean=8967",
        "Hispanic or Latin American=5022"
      ],
      "otg_id": "GCST006061",
      "neg_log_pval": 9.154901959985743,
      "gwas_catalog_id": "GCST006061",
      "pubmed_id": "29892015"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000055118",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SOTALOL is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug IBUTILIDE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DOFETILIDE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug AMIODARONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "7",
        "position": 150964321
      },
      "alleles": {
        "reference": "G",
        "alternative": "A"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000275"
      ],
      "reported_trait_name": "Atrial fibrillation [EA]",
      "standard_trait_name": "atrial fibrillation"
    },
    "association_info": {
      "ancestry": [
        "European=537409",
        "East Asian=36792",
        "African American or Afro-Caribbean=8967",
        "Hispanic or Latin American=5022"
      ],
      "otg_id": "GCST006061_3",
      "neg_log_pval": 10.045757490560675,
      "gwas_catalog_id": "GCST006061",
      "pubmed_id": "29892015"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000055118",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug SOTALOL is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug IBUTILIDE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DOFETILIDE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug AMIODARONE is approved for the indication atrial fibrillation (EFO_0000275) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "7",
        "position": 150993088
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000612"
      ],
      "reported_trait_name": "Myocardial infarction",
      "standard_trait_name": "myocardial infarction"
    },
    "association_info": {
      "ancestry": [
        "European=388806"
      ],
      "otg_id": "SAIGE_411_2",
      "neg_log_pval": 9.03526907894637,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000055118",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug AMIODARONE is approved for the indication heart failure (EFO_0003144) and targets the gene ENSG00000055118 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "9",
        "position": 5049092
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0002429"
      ],
      "reported_trait_name": "Polycythaemia vera | non-cancer illness code, self-reported",
      "standard_trait_name": "polycythemia vera"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1438",
      "neg_log_pval": 19.559482903933304,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000096968",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug RUXOLITINIB is approved for the indication polycythemia vera (EFO_0002429) and targets the gene ENSG00000096968 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "9",
        "position": 5049092
      },
      "alleles": {
        "reference": "G",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0002429"
      ],
      "reported_trait_name": "Polycythemia vera",
      "standard_trait_name": "polycythemia vera"
    },
    "association_info": {
      "ancestry": [
        "European=401535"
      ],
      "otg_id": "SAIGE_200_1",
      "neg_log_pval": 16.707743928643524,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000096968",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug RUXOLITINIB is approved for the indication polycythemia vera (EFO_0002429) and targets the gene ENSG00000096968 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "9",
        "position": 5070831
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0004251"
      ],
      "reported_trait_name": "Myeloproliferative neoplasms",
      "standard_trait_name": "myeloproliferative disorder"
    },
    "association_info": {
      "ancestry": [
        "European=3323"
      ],
      "otg_id": "GCST000357",
      "neg_log_pval": 19.397940008672037,
      "gwas_catalog_id": "GCST000357",
      "pubmed_id": "19287384"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000096968",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug RUXOLITINIB is approved for the indication primary myelofibrosis (EFO_0002430) and targets the gene ENSG00000096968 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "9",
        "position": 104902020
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "HP_0003124"
      ],
      "reported_trait_name": "High cholesterol | non-cancer illness code, self-reported",
      "standard_trait_name": "Hypercholesterolemia"
    },
    "association_info": {
      "ancestry": [
        "European=361141"
      ],
      "otg_id": "NEALE2_20002_1473",
      "neg_log_pval": 14.698970004336019,
      "url": "http://www.nealelab.is/uk-biobank"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000165029",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PROBUCOL is approved for the indication Hypercholesterolemia (HP_0003124) and targets the gene ENSG00000165029 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "9",
        "position": 104903697
      },
      "alleles": {
        "reference": "C",
        "alternative": "G"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003774"
      ],
      "reported_trait_name": "Hyperlipidemia",
      "standard_trait_name": "hyperlipidemia"
    },
    "association_info": {
      "ancestry": [
        "European=408878"
      ],
      "otg_id": "SAIGE_272_1",
      "neg_log_pval": 7.73754891026957,
      "doi": "10.1038/s41588-018-0184-y"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000165029",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug PROBUCOL is approved for the indication hyperlipidemia (EFO_0003774) and targets the gene ENSG00000165029 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "9",
        "position": 120878222
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0000540"
      ],
      "reported_trait_name": "Celiac disease or Rheumatoid arthritis",
      "standard_trait_name": "immune system disease"
    },
    "association_info": {
      "ancestry": [
        "European=38053"
      ],
      "otg_id": "GCST000987",
      "neg_log_pval": 10.397940008672037,
      "gwas_catalog_id": "GCST000987",
      "pubmed_id": "21383967"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000106804",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ECULIZUMAB is approved for the indication immune system disease (EFO_0000540) and targets the gene ENSG00000106804 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "X",
        "position": 67801708
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001663"
      ],
      "reported_trait_name": "Prostate cancer",
      "standard_trait_name": "prostate carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=13560"
      ],
      "otg_id": "GCST001148",
      "neg_log_pval": 8.0,
      "gwas_catalog_id": "GCST001148",
      "pubmed_id": "21743467"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169083",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug APALUTAMIDE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000169083 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABIRATERONE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000169083 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BICALUTAMIDE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000169083 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug FLUTAMIDE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000169083 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ENZALUTAMIDE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000169083 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "X",
        "position": 67801708
      },
      "alleles": {
        "reference": "C",
        "alternative": "T"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0001663"
      ],
      "reported_trait_name": "Prostate cancer",
      "standard_trait_name": "prostate carcinoma"
    },
    "association_info": {
      "ancestry": [
        "European=140254"
      ],
      "otg_id": "GCST006085",
      "neg_log_pval": 9.0,
      "gwas_catalog_id": "GCST006085",
      "pubmed_id": "29892016"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000169083",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug APALUTAMIDE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000169083 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ABIRATERONE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000169083 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug BICALUTAMIDE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000169083 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug FLUTAMIDE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000169083 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        },
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug ENZALUTAMIDE is approved for the indication prostate carcinoma (EFO_0001663) and targets the gene ENSG00000169083 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  },
  {
    "sentinel_variant": {
      "locus_GRCh38": {
        "chromosome": "X",
        "position": 155050522
      },
      "alleles": {
        "reference": "T",
        "alternative": "C"
      }
    },
    "trait_info": {
      "ontology": [
        "EFO_0003907"
      ],
      "reported_trait_name": "Thrombosis",
      "standard_trait_name": "deep vein thrombosis"
    },
    "association_info": {
      "ancestry": [
        "European=258962"
      ],
      "otg_id": "GCST003390",
      "neg_log_pval": 12.154901959985743,
      "gwas_catalog_id": "GCST003390",
      "pubmed_id": "26908601"
    },
    "gold_standard_info": {
      "gene_id": "ENSG00000185010",
      "evidence": [
        {
          "class": "drug",
          "confidence": "High",
          "curated_by": "Ed Mountjoy",
          "description": "The drug DROTRECOGIN ALFA (ACTIVATED) is approved for the indication Recurrent thrombophlebitis (HP_0004419) and targets the gene ENSG00000185010 at this locus",
          "source": "ChEMBL - Open Targets Evidence 19.06"
        }
      ]
    },
    "metadata": {
      "date_added": "2019-07-17",
      "reviewed_by": "Ed Mountjoy",
      "set_label": "ChEMBL",
      "submitted_by": "Ed Mountjoy",
      "tags": [
        "drug",
        "ChEMBL"
      ],
      "comments": "Gold-standard derived from approved drug-indication pairs in ChEMBL"
    }
  }
]